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EPMA was created in 2009 as the Forum for Predictive, Preventive and 
Personalised Medicine (PPPM). During the 8 years since then, EPMA 
meetings – in the form of world congresses and international summits [1- 
3] – have traditionally included multi-professional presentations, discus- 
sions, considerations, publications, and consolidation in the field of 
PPPM. The EPMA Journal releases over 90% of publications dedicated 
to PPPM worldwide, acting as the leading journal in the field. EPMA 
currently comprises a network of over 50 countries globally, actively 
contributing to the innovative concepts of PPPM. For more information, 
please see www.epmanet.eu 
 The EPMA World Congress 2017 in Malta is specifically focused on the 
following topics: PPPM in Cancer, PPPM in Neurodegenerative 
Neurological Neuropsychiatric Disorders (NNND), PPPM in 
Cardiovascular Disease, PPPM in Diabetes Mellitus and related patholo- 
gies, PPPM in Dentistry, Innovative Technologies in PPPM, and 
Innovative PPPM Strategies in Healthcare. 
 Global challenges and PPPM-solutions: Long-term strategies of the EPMA 
(keynote speech by the EPMA Secretary-General, Prof. Dr. Olga 
Golubnitschaja, September 14th) will be presented based on the BEPMA 
position paper 2016^ as the fundamental document of the association [4]. 
Several approaches have been suggested in modern medicine for 
optimising medical services, including person-centred, personalised, 
individualised, and precision medicine. The great plurality of approaches 
indicates a broad understanding of clear deficits which do exist in cur- 
rently applied medical services and the attempts of diverse professional 
groups to remedy them. On the other hand, there is a growing understand- 
ing that persisting deficits are fundamental in nature and, therefore, can- 
not be solved by superficial modifications of health care systems facili- 
tating individual technologies such as Bcancer genomics^ by Bprecision 
medicine.^ Global deficits are well-defined and have been described else- 
where as unpredictable, unpreventable, and impersonal medicine. It is 
 
 
evident that a paradigm shift is needed to move from Breactive^ to 
Bpredictive, preventive and personalised medicine  ^as a new philosophy 
for medical services covering both Bhealth care  ^and Bdisease care ,^ promot- 
ing an integrated approach combining advantages of individual biomedical 
fields and technologies, and consolidating a multi-professional collaboration. 
An individual with an actual or potential disease wants a medicine in which 
he/she is at the centre, a medicine which is tailored to his/her polymorphism, 
a medicine which is able to provide him/her with the right therapy, in the right 
dose, at the right moment, for the right period of time. But he/she also wants a 
medicine which is able to predict and prevent possible diseases. He/she is not 
interested in the way in which this kind of medicine is described. However, 
he/she is interested in understanding why it is described in that way, in order 
to appreciate its potential to restore health. And this is the real advantage of 
speaking in terms of predictive, preventive, and personalised medicine: the 
actual or potential patient understands what is going on! Nevertheless, there is 
something more. PPPM lends itself to the role of an overarching umbrella 
under which the main ethical issues of contemporary biomedicine can be 
positively tackled. 
 Flammer syndrome (FS) in the context of PPPM (keynote speech by Prof. 
Dr. Josef Flammer and Dr. Katarzyna Konieczka, Ophthalmologic Clinic, 
University of Basel, September 15th) will present a special phenotype/ 
health condition which is clearly relevant for disease development and 
individual outcomes in several pathologies including glaucoma, multiple 
sclerosis, breast cancer, and metastatic disease, amongst others [5-9]. FS 
is frequently observed in young populations (the symptoms appear early 
in puberty), making innovative PPPM approaches particularly meaning- 
ful in the area of population screening, predictive diagnostics, targeted 
prevention, and individualised prognosis. 
 Innovative healthcare strategies 
PPPM represents only innovative biomedical sciences but also advanced 
healthcare services focusing on the patient’s needs and the most optimal 
solutions for society as the whole. The practical aspects of the paradigm 
change from BunPPPM  ^to PPPM will be discussed at dedicated sessions 
including global healthcare benefits (keynote speech by Prof. Dr. Russel 
Andrews, NASA, USA, September 16th), socioeconomic aspects of the 
PPPM implementation, and creation of new institutions to facilitate the de- 
velopment of PPPM services in healthcare. 
 Breast Cancer Epidemic in the early Twenty-First century [10] is the 
Bleitmotiv^ of the specialised congress session BPPPM in Cancer .^PPPM 
 approaches will be discussed to apply multi-level diagnostics in order to 
 improve the patient stratification, prediction of disease development and 
 progression, targeted preventive measures, and personalised treatment 
 algorithms [11]. 
 PPPM i n N eurological, Neurodegenerative a nd Neuropsychiatric 
 Disorders (NNND) is a specialised session which will present the top 
expertise in the relevant areas including computer-assisted disease- 
modelling, personalised approaches to diagnosis and treatment in psychi- 
atry, neuroinflammation, neurodegeneration, suboptimal health condi- 
tions, and comorbidities, amongst others. 
 PPPM in Diabetes Mellitus is a specialised session dedicated to the inno- 
vative approaches for predicting, preventing, and effectively treating the 
metabolic syndrome, its pre-stages and comorbidities, and special health 
conditions such as pregnancy. 
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PPPM in Cardiovascular Disease (CVD) is a specialised session featuring 
a collection of innovative data regarding CVD prevention in stratified 
cohorts, as well as molecular pathways targeted for CVD prediction and 
prognosis. 
 PPPM in Dentistry is a specialised session with multi-professional 
expertise which will present a whole spectrum of the field related 
innovation including the role of stem cells in tooth regeneration 
(keynote speech by Prof. Dr. Mahmood Mozaffari, University of 
Augusta, USA, September 16th), dental health in childhood, caries 
prevention in stratified patient cohorts, personalised orthopaedic 
treatments, and prevention of severe complications in CVD pa- 
tients with dental pathologies, amongst others. 
 Innovative Technologies in PPPM is a specialised session with multi- 
professional expertise which will introduce unique technologies such as 
liquid biopsy (keynote speech by Prof. Dr. Evi S. Lianidou, University of 
Athens, Greece, September 15th), health condition-specific biomarker 
panels discovered in human tear fluid and saliva, and disease-specific 
multi-omics approaches, amongst others. 
 Workshop of young professionals in PPPM (EPMA-YPS, September 
14th) is the traditional session presenting new ideas developed by young 
researchers, including BMini-encyclopaedia of Wound Healing: Lessons 
for PPPM^, BLongevity – good luck or reasonable lifelong healthcare 
strategy?^ The best presentations chosen by the international jury-board 
of prominent scientists will be awarded by the EPMA. The award cere- 
mony will take place on September 16th. 
The University of Malta, as the host of the EPMA World Congress 2017, 
has created an excellent platform for an effective congress and a pleasant 
atmosphere for the thematic sessions scheduled in the congress pro- 
gramme, as well as spontaneous professional meetings to exchange pro- 
fessional information and to plan new, successful projects in PPPM. 
 
 
 
Welcome to the EPMA World Congress 2017 in Malta – enjoy the meeting! 
 
   
 
Prof. Dr. Godfrey Grech  Prof. Dr. Olga Golubnitschaja 
Secretary-General of the EPMA 
Dr. Vincenzo Costigliola 
President of the EPMA 
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Abstract 
The breast cancer (BC) epidemic in the twenty-first century is evi- 
denced by the approximately two million new cases and half-million 
related deaths annually worldwide [1]. The overall situation is particu- 
larly dramatic in specific subgroups such as those with triple-negative 
BC: more than 50% of these patients die of metastatic BC within the 
first 6 months of diagnosis. Consequently, breast cancer management in 
general should be thoroughly reconsidered, promoting a new paradigm 
based on predictive diagnostics, new screening programs, targeted pre- 
vention and individually tailored treatments. Due to the extremely high 
level of complexity of the field, the new paradigm represents a spec- 
trum of complementary components that constitute the innovative 
PPPM concept. At the EPMA World Congress 2015, the dedicated 
working group elaborated the working hypothesis and concepts for a 
multi-centre pilot project; this action has consequently been taken [2], 
and the new knowledge collected will be summarised. The overall 
results substantially extend the Bseed and soil^ theory of metastasis 
with the finding that among individuals at risk, a strong predisposition 
toward the formation of the systemic hypoxic pre-metastatic niches can 
be established long before the breast malignancy is clinically manifest- 
ed [3]. The BFlammer syndrome^ phenotype may strongly contribute to 
BC onset [4] and aggressive metastatic disease with particularly poor 
outcomes [4]. Both pre- and postmenopausal women may be affected 
[3-5]. Individualised patient profiles and the involvement of primary 
caregivers (family doctors) are essential for implementation of PPPM 
in BC management [5]. 
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Abstract 
Molecular medicine has evolved rapidly over the past decade, focusing on 
genetics and cellular mechanisms of disease, providing knowledge on (1) 
causative genes in monogenic diseases and syndromes, as well as suscepti- 
bility genes that work in concert with other genetic and environmental factors 
to elicit the disease; and (2) deregulated mechanisms within specific subtypes 
of disease, to classify patients molecularly and to identify potential or already 
known therapeutic targets. In oncology, research and its evidence-based sci- 
entific outcomes have evolved from the lab bench to bedside, implementing 
the use of biomarkers as classifiers of therapeutic groups; characterization of 
syndromes with high risk for specific disease, hence providing the opportu- 
nity for risk reduction strategies; predictive biomarkers to guide treatment 
type, dose and toxicity; and prognostic biomarkers to define specific clinical 
outcomes. Preventive genetics plays a role in defining specific genetic disor- 
ders through population screening for carriers of rare, fully penetrant alleles 
that cause monogenic diseases, and genotyping of susceptibility genes within 
families at high risk of developing a specific disease, providing the basis of 
public health genetics. Predictive genetics deals with the efficacy and toxicity 
of drugs in individuals. Breast cancer will be discussed as a model for the use 
of molecular markers; the use of technology to bridge the gap between lab- 
oratory and clinical setting; and the need for novel targets to overcome 
targeted therapy resistance. The uptake of molecular medicine in the 
healthcare system requires continuous education of healthcare professionals 
and proper dissemination of information within the healthcare system. 
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Abstract 
Breast cancer (BC), the leading cancer in women, is increasing in prev- 
alence worldwide, concurrent with western metabolic epidemics includ- 
ing obesity, metabolic syndrome, and diabetes, and shares major risk 
factors with these diseases. Here, potential dietary contributions to BC 
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prevention are reviewed, with a focus on their pathometabolic 
trajectories. 
The development of BC potentially involves diet-related pro-oxi- 
dative, inflammatory, and pro-carcinogenic processes, i.e. through 
lipid/fatty acid peroxidation, estrogen metabolism, related DNA 
adduct depurination, and mutation formation [1]; free fatty acids 
(FFA),  e.g.  the  n-6  polyunsaturated  fatty  acid  (PUFA)  linoleic 
acid, have been associated with BC migration and invasion [2]. 
The pathometabolic trajectory is affected by high estrogen, insulin, and 
growth factor cascades and the resultant accelerated proliferation/ 
progression [3]. Anthropometric measures – high birth weight, adult tall- 
ness, fatness/body mass index (BMI), and weight-gain – are often reflec- 
tive of these factors [3, 4]. 
A gender-based approach targets women’s specific nutritional risk 
in western obesogenic environments, i.e. with increasing adiposity, 
estrogen metabolism, and n-6 PUFA conversion to pro-inflamma- 
tory/carcinogenic eicosanoids under high n-6:n-3 PUFA ratio con- 
ditions [5]; and as related  to the timing of  life  events,  such as 
lower age at menarche, late full-term pregnancy, and early meno- 
pause [6]. 
Recent large-scale studies have confirmed the effectiveness of evidence- 
based recommendations against BC risk, emphasizing low dietary energy 
density (ED), nutritious plant-based diets, physical activity, and body/ 
abdominal adiposity management [7, 8]. 
A better understanding of dietary interrelationships with BC and 
recommended dietary patterns – e.g. Mediterranean, DASH, plant- 
based, low-ED, and glycemic load (GL), with high nutrient/ 
phytonutrient density – will be discussed, with emphasis on the 
need for personalized adaptation to support early/timely prevention, 
optimally merging with other dietary/health goals, for lifelong BC 
prevention. 
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Abstract 
Breast cancer is by far the most common cancer in women world- 
wide. The World Health  Organization  (WHO)  claims  that  there 
are about 1.38 million new cases and 458,000 deaths from breast 
cancer each year [1]. The Malta Cancer registry showed that 13% 
of cancer deaths in Malta are due to breast cancer, the  second 
highest rate in the EU [2]. 
Exploring the molecular difference among breast cancer subtypes is 
of crucial importance in understanding its heterogeneity and seeking 
its effective clinical treatment. Predicting drug response in cancer 
patients remains a major challenge in the clinic; one of the reasons 
is heterogeneity [3]. Ex vivo culturing enables a personalized cul- 
ture method, which allows for investigation of anti-tumoral pharma- 
cological properties that preserves the original cancer microenviron- 
ment [4]. It is believed that molecular predictive markers may form 
the basis for tailoring an individual’s adjuvant therapy based on the 
genetic fingerprint of their cancer. 
This study aims to assess heterogeneity in breast cancer tissue 
resected in Malta using both routine immunohistochemistry and 
that specific to the PI3K/pAkt pathway. Using LIS, PATHSA and 
iSOFT software, a curated dataset of patients who had document- 
ed tumoral heterogeneity between 2008 and 2015 was created. 
Demographics that were noted included gender, age, histology 
types, Bloom-Richardson grade, type of surgery the patient 
unde rwe n t , pr es ence  of axi l  la ry mi c rome t a s t a s i s o r 
macrometastasis, and vascular invasion. The tissue blocks with 
confirmed heterogeneity were traced using LIS software and re- 
trieved from the storage unit. Sections from these tissue blocks 
were used to run tests to assess tissue architecture with H&E and 
immunohistochemistry. Different techniques for ex vivo culturing 
of breast tissue are explored. Results will be analysed using 
SPSS. 
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Abstract 
Research background 
 
The breast cancer (BC) epidemic is a hallmark of the early twenty-first cen- 
tury [1]. BC is a multifactorial disease: BC experts utilise the plural form, now 
referring to Bbreast cancers  ^[2]. Contextually, the BC patient cohort demon- 
strates the whole spectrum of subgroups, including both antipodes: on one 
side this is the Bpostmenopausal breast cancer as the European challenge  ^[3], 
and on the other the particularly aggressive premenopausal Bmetastatic breast 
cancer  ^[4]. The latter subgroup is particularly unpredictable, comprising 
sporadic BC cases with highly promoted metastatic spread to the vital organs 
[5]. Although postmenopausal BC cases still represent the majority of the 
overall patient cohort, recent statistics demonstrate that young populations are 
increasingly affected by BC [1]. Therefore, the old rule "the older the age, the 
higher the BC risk" is becoming relativized. Contextually, BC prediction and 
consequent prevention is a highly complex task requiring effective computa- 
tion of individual patient profiles and precise modelling of the disease [1]. 
Results and conclusions 
Our pilot project dedicated to the predictive modelling of BC has utilised data 
collected using a multi-level diagnostic approach in BC patients versus breast 
benignancy. The study revealed two clearly separate clusters with high versus 
low BC similarity in premenopausal BC-free individuals. The developed mod- 
el is capable of distinguishing Bhigh  ^and Blow  ^BC risk with high confidence 
(>90%). This diagnostic approach is based on a disease-specific molecular 
signature including signalling and detoxification pathways, longevity-related 
proteins, regulation of cytoskeleton, and tissue remodelling. Large-scale vali- 
dation of the clinical utility of the model is under consideration. 
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Abstract 
The breast cancer (BC) epidemic is currently recognised as a feature of 
the early twenty-first century, with almost two million new cases and a 
half-million BC-related deaths recorded annually [1]. Over 90% of all BC 
cases are sporadic in nature, which means currently unpredictable. The 
main cause of BC-related deaths is aggressive metastatic disease to distant 
organs – bones, lung, liver and brain, amongst others. 
The premenopausal triple-negative breast cancer (pTNBC) subtype is 
characterised by particularly low predictability and poor prognosis: early 
diagnostic methods are underdeveloped and therapy approaches are rath- 
er un-targeted. Consequently, more than 50% of these patients die within 
the first 6 months of the diagnosis of metastatic disease [2], and up to 30% 
experience brain metastasis, with particularly poor outcomes [3]. 
Individualised profiling for advanced patient stratification has been rec- 
ommended through the introduction of innovative patient management 
by prediction, prevention and personalised treatment algorithms for this 
highly specific patient cohort [4]. 
The predictive molecular signature in the blood of pTNBC patients has 
been identified using differential molecular profiles by protein patterns of 
circulating leukocytes, specific serum metabolites and subcellular imag- 
ing to evaluate the quality of chrDNA. Statistically significant differences 
have been demonstrated for the molecular signature of pTNBC patients 
compared to those with premenopausal benignancy, premenopausal E/P- 
receptor-positive BC and all postmenopausal BC. Additional stratifica- 
tion by the activity level of MMP2 and MMP9 in blood serum further 
improves the overall predictive power of our diagnostic approach [5]. As 
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for the next stage, a large-scale validation in a multi-centre study is cur- 
rently planned. 
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Objective: Triple-negative breast cancer (TNBC) patients derive little 
benefit from target-specific therapies due to a lack of favourable prognos- 
tic targets, ER, PR and HER2. The aim of this project was to define 
biomarkers to measure PP2A complex activity in breast cancer predicting 
a novel therapeutic class. 
Methods: A multiplex assay using branched DNA technology was used to 
measure the expression of 40 genes in RNA derived from cell lines (n=12) 
and formalin-fixed, paraffin-embedded (FFPE) archival material from 
breast cancer patients (2009–2011). First, the PP2A activity biomarkers 
(PABs) were validated in breast cancer cellular models and compared to 
real-time PCR results. The QuantiGene 2.0 multiplex assay was used to 
measure expression of these markers in a cohort of laser-microdissected 
breast cancer (n=97) and normal breast tissue cases (n=30). Sensitivity of 
cell lines to FTY720 was measured using MTT assays. 
Results: Overexpression of these biomarkers in cell lines predicted sen- 
sitivity to FTY720 and were down-regulated in a dose-dependent manner. 
Of interest, 37% of TNBC cases expressed high levels of PABs, and were 
associated with negative prognostic indicators (P = 0.023). 
Conclusion: TNBC cell lines sensitive to the PP2A activator FTY720 
showed a high expression of PABs. Using patient material, PAB overex- 
pression was common in the TNBC subtype. The novel biomarkers 
(PABs) provide a multiplex gene expression signature for a potential 
therapeutic group sensitive to PP2A activators. 
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Abstract 
Ageing has been associated with a great number of chronic and severe 
pathologies including cardiovascular disease, neurodegenerative disor- 
ders and cancer [1]. According to recent scientific reports, breast tissue 
is far older than other tissues in the body [2]. Consequently, accelerated 
ageing might be a specific risk factor for breast cancer development. Here 
we summarise currently available facts to support this hypothesis. 
 Lifestyle factors involved in both accelerated ageing and breast cancer risk: 
Educational level, sociodemographic and marital status; tobacco and al- 
cohol consumption; sedentary lifestyle against physical activity; partici- 
pation in social networks and leisure activities; workload and occupation- 
al environment; nutrition and diet composition; sleep patterns [3]. 
 Pathologies associated with both a geing a nd (breast) cancer 
 predisposition: 
Overweight/obesity; chronic inflammation; diabetes mellitus; autoim- 
mune diseases; endocrine dysfunction; immune dysfunction; cognitive 
dysfunction; dental disorders; impaired wound healing [1,4,5]. 
 Specific patient profiles for predictive diagnostics and targeted preventive 
measures: 
 
Genetic predisposition (inborn syndromes, symptoms and disor- 
ders); specific molecular profiles (biomarker panels including 
Bintrinsic epigenetic age acceleration^ profiles, CpG-methylation 
patterns, detoxification pathways, DNA-repair patterns, energy bal- 
ance, amongst others) in blood, saliva and urine; symptoms of the 
pathologies associated with ageing (such as impaired wound 
healing); lifestyle factors listed above. 
The presented profiles are the subject of follow-up studies to be validated 
for their practical application within innovative population screening and 
educational programmes. 
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Abstract 
Diagnosis of breast cancer subtypes determines therapeutic options 
and prognosis. These subtypes are hallmarked by the expression of 
the human epidermal growth factor receptor 2, and oestrogen and 
progesterone receptors (HER2, ER and PgR). An audit of breast 
cancer diagnosed in Malta between 2009 and 2016 indicates that 
85% were ER-positive, 11% were HER2-positive, and 10% were 
negative for  all receptors. Current guidelines for diagnosis of 
HER2 are based on immunohistochemistry and confirmatory test- 
ing by fluorescent in situ hybridisation (FISH). HER2 copy num- 
ber assessment on 960 breast cancer samples (cBIOPortal [1, 2]) is 
estimated to detect 1.3% amplification in the absence of expression 
(false positives) and 4.2% diploid accompanied by overexpression 
of the gene (false negatives). 
A multiplex branched DNA assay has been validated for quantify- 
ing gene expression on degraded RNA derived from formalin- 
fixed paraffin-embedded (FFPE) breast cancer tissue [3]. Using 
the diagnostic results as benchmark, this assay has average sensi- 
tivity and specificity of 100% and 97.8% for the determination of 
HER2 status and ER status, respectively. The gene expression 
assay is a novel, quick multiplex method that can accurately diag- 
nose breast cancer subtypes, eliminating subjectivity of interpreta- 
tion and minimising technical variation. This method has a wide 
range of possible applications in the diagnosis of tumours and is 
adapted to the current diagnostic workflow. 
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Abstract 
Human epidermal growth factor receptor 2 (HER2)-positive breast 
cancer cases constitute about 11% of the local breast cancer bur- 
den. These patients are candidates for targeted treatment with the 
anti-HER2 monoclonal  antibody trastuzumab (Herceptin®, 
Genentech), in conjunction with chemotherapy and hormonal ther- 
apy if required, as an adjuvant or neoadjuvant to surgery in oper- 
able cases. The rates of clinical response to treatment have not yet 
been recorded locally. A retrospective clinical audit is thus cur- 
rently in progress in collaboration with the Sir Anthony Mamo 
Oncology Centre (SAMOC). All HER2-positive breast cancer pa- 
tients tested between 2010 and 2016, extracted from Mater Dei 
Hospital laboratory records, were included for the review of pa- 
tient clinical records from their treatment history files. The follow- 
ing information is being collected where available: 
• Date of initial diagnosis 
• Age at diagnosis 
• Tumour stage and pathological grade 
• Treatment regime (adjuvant, neoadjuvant or treatment for advanced 
disease) 
• Tumour measurements before and during/after treatment 
• Date of recorded tumour progression/metastasis/new lesion 
diagnosis 
• Date of death in the case of deceased patients 
All clinical and radiological responses are given  a  final  assess- 
ment using the Response Evaluation Criteria In Solid Tumors 
(RECIST) 1.1. The findings to date will be presented and com- 
pared to published findings in other countries. This  audit  will 
allow treatment response rates to be correlated to laboratory find- 
ings on archival tissue specimens in the ongoing Breast Cancer 
Project at the University of Malta. 
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Abstract 
Background. CA 19-9  is  the  only  approved biomarker for  moni- 
toring tumor response in patients with pancreatic adenocarcinoma 
(PDAC), but it has several limitations, highlighting the need for 
new predictive biomarkers [1]. Mutant KRAS is a driving onco- 
gene, occurring in 75–95% of PDAC [2]. 
Aim. To develop an analysis tool based on plasma to monitor the varia- 
tion in mutant KRAS alleles in PDAC being treated with first-line 
chemotherapy. 
Methods. Twenty-seven PDAC patients were enrolled in this 
study. Six milliliters of plasma were prospectively collected at 
baseline, after 15 days of chemotherapy and at each clinical fol- 
low-up.  CftDNA was  extracted  from  plasma  with  a  specific  kit 
and analyzed by the Droplet Digital™ PCR (ddPCR) for KRAS 
mutations in codon 12 (G12X) and G13D. 
Results. At baseline, 19 out of 27 patients (70.3%) were carriers 
of one of the KRAS mutations. Eight patients had a negative 
cftDNA mutKRAS at baseline, and one out of eight became pos- 
itive at day 15, and another one at the first radiological evalua- 
tion. There was a statistically significant difference in progression- 
free survival (PFS) between patients with increased vs. stable/ 
reduced cftDNA at  the 15-day sample (median PFS 2.5 vs. 7.5 
months, p=0.03; see Fig. 1). A statistically significant difference 
was also observed in median overall survival (OS; 6.5 vs. 11.5 
months in cftDNA increase vs. reduction, respectively, p=0.009). 
Conclusions. cftDNA analysis of mutKRAS could be a reliable non-
invasive approach for early prediction of tumor progression and 
responsiveness to chemotherapy. However, in order to assess 
these preliminary data, further analyses are needed. 
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Fig. 1 PFS according to cftDNA mutKRAS variation at day 15 
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Abstracts 
MicroRNAs represent an emerging class of non-coding RNAs with sig- 
nificant functions in the post-transcriptional regulation of gene expres- 
sion. As they also regulate oncogenes and tumour-suppressive genes, 
microRNAs play an important role in the process of malignant 
transformation. 
The aim of this study was to evaluate expression levels of selected 
candidate microRNAs (miR-221, miR-143, miR-145, miR-133a, 
miR-146, miR-31 and Let-7 g) in the peripheral blood of 95 lung 
cancer patients and 100 matched healthy control individuals. We 
used RNU48  as a reference gene. RNU48 was identified by 
geNorm and NormFinder algorithms as the most appropriate for 
the normalization of the microRNA expression in peripheral blood. 
The expression level of miR-143 was significantly higher (p < 
0.0001), whereas the expression level of miR-221 (p = 0.000253) 
was significantly lower, in the blood samples of patients with lung 
cancer in comparison to the control group. Based on the capacity of 
these miRNAs to discriminate patient and control samples, we sug- 
gest that after further validation, these microRNAs could serve as 
potential non-invasive diagnostic biomarkers in lung cancer. 
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Abstract 
Background. In non-small cell lung cancer (NSCLC) patients, the effi- 
cacy of treatment with EGFR tyrosine kinase inhibitors (EGFR-TKIs) 
depends on activating EGFR mutations [1]. However, in half of cases, 
inhibition of EGFR may select resistant cells displaying the EGFR 
p.T790M point mutation [2]. 
Aim. To monitor the early variation in EGFR mutations in NSCLC patients 
using circulating cell-free tumor DNA (cftDNA) extracted from plasma. 
Methods. Seventy-nine NSCLC patients were enrolled in this ongoing 
explorative study. Six milliliters of plasma was prospectively collected at 
baseline and at each clinical follow-up. CftDNAwas extracted from plas- 
ma with the QIAamp Circulating Nucleic Acid Kit (Qiagen®) and ana- 
lyzed using the Droplet Digital PCR (ddPCR; (BioRad®) for EGFR 
p.L858R, exon 19 deletions and p.T790M mutations. 
Results. Forty-four patients testing positive for EGFR activating mutation 
were treated with the first-generation EGFR-TKIs, while 35 patients testing 
positive for p.T790M at baseline were treated with AZD9291, the potent, 
irreversible EGFR-TKI selective for the p.T790M mutation. During the treat- 
ment with first-generation TKIs, nine patients experienced clinical progres- 
sion after a median of 9 months and, testing positive for p.T790M, switched 
therapy to AZD9291. Interestingly, the appearance of low levels of activating 
EGFR mutations anticipated the appearance of both high levels of the resis- 
tance mutation and clinical progression occurring several months later. 
Conclusions. CftDNA analysis is useful not only for monitoring clonal 
evolution of NSCL cancer cells under the stress of EGFR-TKIs, but also 
in evaluating treatment responses and choosing the more effective therapy 
in individual patients. 
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Abstract 
The availability of CTCs as liquid biopsies suggests the potential for study- 
ing dynamic change(s) in CTCs during the course of therapy, thus informing 
both treatment and drug development. Small cell lung cancer (SCLC) has a 
poor prognosis due to rapid growth, early tumor spread, and unavoidable 
drug resistance [1]. It has been suggested that the CTC number and persis- 
tence in SCLC is highly prognostic, which could be of clinical utility for 
guiding disease management or in early clinical trials of novel agents [2]. A 
major challenge in the clinical utilization of CTCs is their rarity, and several 
approaches have been taken for their enrichment, each with its limitations 
and with no one clearly superior. We, therefore, developed a completely 
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flexible rare-cell imaging approach that could be applied to CTCs enriched 
by any desired method. Enrichment can be marker-based, size-based, or 
microfluidic, or large (two million per slide) numbers of cells can be scanned 
quickly and efficiently, requiring no enrichment. This approach was able to 
detect a single tumor cell in one million peripheral blood mononuclear cells 
(PBMC), with either filtration-based enrichment or no enrichment. CTCs 
were identified in patients with a variety of cancers [3], utilizing both tumor- 
specific antibodies and fluorescent in situ hybridization (FISH) markers for 
the detection of aneuploidy. Analysis of a 2-ml blood sample from an SCLC 
patient identified eight CTCs (Fig. 1). This uniquely flexible approach per- 
mits the interrogation of a CTC for up to five nucleic acid or protein markers, 
allowing, in addition to enumeration, the molecular characteristics of the 
detected CTCs to be explored. 
 
 
 
 
Fig. 1 CTC detected in an SCLC patient based on the presence of a 
DAPI-stained nucleus (top left), expression of EpCAM (bottom left), 
and lack of CD45/CD31 expression (top right). A composite image of 
the DAPI, EpCAM, and CD45/CD31 channels is shown at the bottom 
right. 
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Abstract 
Glioblastoma multiforme (GBM) represents one of the most malig- 
nant tumors of the primary central nervous system in adults, with 
considerably high mortality [1,2]. Standard therapies including neu- 
rosurgery, radiotherapy and chemotherapy with temozolomide have 
only a limited effect on the long-term survival of GBM patients 
[3,4]. A number of targeted anti-cancer therapeutics, including 
low-molecular-weight tyrosine kinase inhibitors or monoclonal an- 
tibodies, have been evaluated in numerous clinical trials with newly 
diagnosed as well as recurrent GBM. Unfortunately, until today, 
only one targeted anti-tumor drug – the antiangiogenic inhibitor 
bevacizumab – has been approved for the treatment of recurrent 
GBM, albeit not in the EU [5]. Moreover, its effect on the overall 
survival of patients with recurrent GBM remains controversial. 
Major advances in cancer immunotherapy over the past few years 
now offer hope for the possible future use of such treatment strate- 
gies for patients with GBM as well [6,7]. This presentation will 
discuss the recent preclinical and early clinical results from studies 
evaluating anti-tumor immunotherapy using so-called immune 
checkpoint inhibitors that might improve the very unfavorable prog- 
nosis of patients with GBM in the near future. This work was sup- 
ported by MH CZ – DRO (Faculty Hospital Plzen - FNPl, 
00669806) and by the National Sustainability Program I (NPU I) 
Nr. LO1503 provided by the Ministry of Education, Youth and 
Sports of the Czech Republic, and by the Charles University 
Research Fund (Progres Q39). 
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Abstract 
Most colorectal cancers are considered sporadic, and often the cause is 
not known. Biomarkers of individual repair capacity (IRC) play a role not 
only in the risk of developing cancer, but also in virtually every aspect of 
the course of the disease. 
In our case–control study of 273 colorectal cancer patients and 187 
cancer-free controls, the 22 single-nucleotide polymorphisms (SNPs) 
in 12 genes (GSTP1, CYP1A2, CYP1B1, CYP2C8, CYP2C9, 
CYP2E1, CYP2W1*2, CYP19A, MTHFR, XRCC1, hOOG1, DPYD) 
were genotyped and analyzed for their correlation with the risk of 
sporadic colorectal cancer in multivariate logistic regression models. 
There were significant genotype associations of the following SNPs: 
rs1695 GSTP1, rs1801133 and rs1801131 MTHFR, rs25487 XRCC1 
rs1052133 hOOG1 and rs1801160 and 1801159 DPYD. Haplotype 
analysis of four DPYD polymorphisms showed significant differ- 
ences in the distribution of the IISt haplotype between cases and 
controls. In comparison to the most common haplotype (VISt), the 
IISt haplotype was associated with increased risk of colorectal cancer 
(p = 0.038, OR = 2.733, 95% CI = 1.019–7.326). 
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Abstract 
Despite recent advances in clinical and experimental colorectal cancer 
(CRC) research, the optimal approach for stratifying CRC patients re- 
mains uncertain. We previously described amplification of TRIB1 and 
MYC in 14.5% and 7.4% of a CRC cohort (n=118), respectively, and 
found these amplifications significantly correlated (p = 0.0001) in a num- 
ber of cases1. Our current aims are (i) to understand the prognostic role 
and function of TRIB1 in CRC, and ii) to identify a clinical and molecular 
signature for this subgroup of patients that can be used for prognostication 
and therapeutic targeting. To this end, we are validating TRIB1 
expression/amplification in 500 Maltese patients diagnosed with CRC 
between 2008 and 2011. A tissue microarray platform was used to quan- 
tify gene amplification by fluorescence in situ hybridisation (FISH) and 
protein expression by immunofluorescence imaging. TRIB1 expression 
will be associated with several clinicopathological parameters. CRISPR/ 
Cas9 technology was used to create three stable TRIB1 knock-down CRC 
cell lines, which were used for functional analysis using the Celigo® 
image cytometer to measure cell cycle progression, proliferation, tumour 
growth, and invasion. Western blotting will be used to interrogate several 
pathways including MAPK, PI3K/AKT, NF-κB, cell cycle, and apopto- 
sis. Our data show that Trib1 protein expression in the patient cohort is 
significantly positively correlated with Akt, BRCA1, Met, Erk, Stat3, 
MEK, Myc, caspase 3, PTEN, Stat3, and CDK2 (p =<0.05). These find- 
ings will fully characterise the TRIB1-positive subgroup, laying the foun- 
dation for therapeutic targeting and companion diagnostics. Correct pa- 
tient stratification increases patient survival, reduces recurrence, and min- 
imises overtreatment. 
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Abstract 
The increasing number of cancer cases and high cancer-related mortality is 
a global problem that requires huge financial investments in both diagnos- 
tics and therapeutic interventions. The most challenging issue for cancer 
therapy is the development of personalized approaches. Despite recent 
advances in our understanding of fundamental aspects of cancer cell biol- 
ogy and the development of anti-cancer therapeutic approaches, 
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accumulating evidence indicates that efficient anti-cancer personalized ther- 
apy is possible only if we consider the role of the immune component of the 
tumor microenvironment in carcinogenesis (1). Another essential factor that 
defines individual responses to chemotherapy is intratumoral heterogeneity. 
This is caused by genomic instability in cancer cells, resulting in the selec- 
tion of resistant clones that can differentially interact with the immune 
component of the immune tumor microenvironment (2). Moreover, we 
have recently found that compartmentalization of the immune component 
in functionally different intratumoral areas is predictive of metastasis effi- 
ciency after neoadjuvant chemotherapy in breast cancer patients (3). 
Targeting specific immune components of the tumor microenvironment is 
a promising treatment strategy that can improve the outcome of conven- 
tional anti-cancer therapy. Modern immunotherapeutic approaches are 
based on targeting of tumor-infiltrating immune cells, including neutro- 
phils, dendritic cells, NK cells, T cells, B cells, and macrophages. The most 
abundant immune cells in the tumor microenvironment are tumor- 
associated macrophages (TAM) that control tumor growth, vascularisation, 
and metastatic spread (4). TAM display a pronounced heterogeneity and 
phenotypic plasticity that offers the possibility of using them as biomarkers 
for predicting individual patient responses to therapy, and stratification of 
patients towards specific therapeutic schemas. TAM intra-tumor heteroge- 
neity and the existence of patient-specific phenotype signatures form the 
basis for the development of novel personalized TAM-based therapeutic 
approaches. 
Funding: Russian Science Foundation №14-15-00350. 
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Evaluation of cytotoxicity of nanoparticles on cancer cells with LDH 
and MTT assays 
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Abstract 
Nanoparticles are gaining increasing popularity as medical tools against 
cancer. Their applications range from diagnostic purposes to possible 
therapeutic interventions. Although the ongoing research has revealed 
some promising results, a serious manifestation of nanoparticle-induced 
adverse effects has been reported by many researchers. Thus, the evalu- 
ation of the cytotoxicity that nanoparticles exert on cells must be thor- 
oughly examined. This study focuses on the response of two cancer cell 
lines, HeLa cervical cancer and H460 lung cancer cells, to zinc oxide, 
gold and silicon dioxide nanoparticles. Cells were exposed to various 
doses over a 24-h period. Cytotoxicity levels were then evaluated by 
MTT and LDH cytotoxic assays. Results showed reduced cell viability 
over both cell lines and for all nanoparticle treatments. However, cyto- 
toxicity levels varied, with correlations to dose-, nanoparticle- or cell- 
dependent cytotoxicity only in specific aspects of the experiment. 
Although further research is needed to reveal the full potential, along with 
the complete range of side effects, of nanoparticles, the versatile perfor- 
mance of these nanoscale materials can be a powerful tool for researchers. 
Thus far, gold nanoparticles have been the most popular in the modern 
face of personalised medicine, with applications in imaging, drug delivery 
and enhancement of conventional therapeutic strategies. In addition, zinc 
oxide and silica nanoparticles have been used in cancer diagnostics and 
therapeutics as well as imaging and drug monitoring, applications that 
make them promising candidates for individually targeted medicine [1-5]. 
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Abstract 
Psychiatry as a clinical discipline is largely driven by a symptom-based 
approach that underpins current diagnostic (e.g. DSM-V) and therapeutic 
decision-making processes. Reliable biological markers are largely absent 
from current diagnosis and treatment. In addition, evaluation of treatment 
efficacy rests solely on patient self-report and clinical judgement. Does 
psychiatry as a field have the opportunity to develop beyond a clinically 
driven Bwait-and-see^ approach [1]? In this presentation, the concept of 
personalized psychiatry will be introduced, which integrates both biolog- 
ical systems and clinical markers, incorporating prevention, prediction 
and participation as key features of personalised medicine. 
The identification of distinct clinical and biological disease trajectories un- 
derscores a prospective and proactive preventive approach to mental illness 
for a large proportion of people at risk for a first or for subsequent episodes 
of mental illness [2,3]. Pre-treatment stratification into meaningful sub- 
groups of patients is a necessary part of personalized psychiatry, in order 
to inform more effective treatment decisions [4]. A specific biologically 
determined clinical subgroup of patients with depressive symptomatology 
consists of patients presenting with increased peripheral inflammatory 
markers that may make these suitable diagnostic markers for clinical strat- 
ification into specific treatment groups. In addition, the genomics of treat- 
ment response to pharmacological and psychological interventions is cru- 
cial for a personalized approach in psychiatry. The prospective and predic- 
tive approach taken in personalized psychiatry requires bioinformatics 
modelling that considers both clinical and biological markers for more 
accurate prediction of disease onset and disease course, as well as prediction 
of treatment needs. Using our multimodal probabilistic prediction model, 
prediction of treatment needs in psychosis have been illustrated [5]. 
The outlined concept of personalized psychiatry as illustrated by several 
examples comprehensively describes key ingredients needed for person- 
alizing the diagnosis and treatment of patients with psychiatric disorders. 
A clinical experimental validation process is essential and among the key 
challenges in personalized psychiatry for the translation of findings into 
clinical practice and guidelines and for patient participation. 
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Abstract 
Imaging of the retina with the help of high-resolution spectral domain 
optical coherence tomography (OCT) has leveraged both clinical and 
preclinical investigations of inflammatory, autoimmune and neurode- 
generative processes that affect retinal tissue and the anterior part of 
the visual pathway. In combination with (ultrahigh-field) MRI, a thor- 
ough investigation of the entire visual pathway from the retina to the 
visual cortex is feasible. Over the past 10 years, our understanding of 
the pathophysiology of retinal damage, and how this relates to global 
disease burden and clinical disability in neuroimmunological and neu- 
rodegenerative diseases such as optic neuritis, multiple sclerosis, neu- 
romyelitis optica, Susac syndrome, Parkinson’s disease, and dementias 
has increased substantially. Consequently, OCT is increasingly used to 
assess patients with autoimmune and neurodegenerative conditions of 
the central nervous system in clinical routine, and the technique is also 
implemented as an outcome tool in clinical trials investigating the vi- 
sual system. In preclinical research, retinal imaging by OCT is used in 
animal models to deepen our understanding of the pathophysiologic 
mechanisms prevailing in these conditions. Both preclinical data and 
clinical applications of retinal imaging techniques in relation to MRI 
findings in various conditions will be presented, and future research 
questions with regard to differential diagnosis and individualized treat- 
ment approaches will be discussed. 
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Abstract 
Proactive healthcare relies on the  capacity  to  detect  health  risk 
and early disease states. The recent Institute of Medicine Report 
on diagnosis has identified diagnosis as a major source of error in 
the health system, even for established disease [1]. Diagnosis and 
the decisions that follow rely on good judgement – often involv- 
ing the assessment of probability and comparisons of predictions 
over time for alternate scenarios. 
Work in psychology around cognitive bias, heuristics and decision- 
making show that humans are poor at these. 
Even the well-trained routinely fail at assessing probability and at 
predicting the outcome of even simple scenarios over time. Recognition 
of these weaknesses and training against them does not fix them – we 
seem unable to correct for our own biases. Indeed, it has been shown in 
well-constructed experiments that our confidence rises as we are more 
likely to predict the wrong outcome [2, 3]. 
Informatics and its machines are important in all aspects of pro- 
active health care, but helping to accommodate for the way that 
people think offers an important opportunity for the advancement 
of predictive, preventive, personalised medicine (PPPM) [4]. 
Machine assistance can help people avoid likely errors and correct 
for biases that will lead to a less rational outcome, but using the 
way  that  people  think  in  a  constructive  way,  they  can  also  be 
used to reinforce the most appropriate interpretation and action. 
Scientific medicine could be made much easier, and informatics and its 
machines can help in new ways. 
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Abstract 
We present the case of a 53-year-old male patient who had been 
suffering from symptoms of decompensated and chronified tinnitus 
for 4 years [1], most likely caused by work stress. In addition, the 
patient developed comorbid decompensated insomnia. Because of 
potential bidirectional connections between tinnitus and sleep disor- 
ders, an interdisciplinary approach to treatment was chosen. The 
treatment plan we developed consisted of ten sessions of repetitive 
transcranial magnetic stimulation (rTMS) for tinnitus [2], followed 
by ten sessions of cognitive behavioral therapy (CBT) for tinnitus 
and insomnia. We used the Tinnitus Questionnaire (TF) to assess 
tinnitus severity, the Beck Depression Inventory (BDI-II) for depres- 
sive symptoms, and the WHO Well-Being Index (WHO-5) for sub- 
jective well-being. Improvements were achieved with regard to ev- 
eryday functioning, as the patient went from decompensated and 
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severe to clinically negligible TF scores, from minimal to no de- 
pressive symptoms, and from just above critical to above average 
well-being. Combining equipment-based and psychological ap- 
proaches to treatment proved successful in this case. We con- 
clude that a combination of rTMS and CBT may be considered 
as an effective treatment for chronic tinnitus and  comorbid 
sleep disorders. 
 
 
References 
 
1. Richter K, Acker J, Miloseva L, Peter L, Niklewski G. Management 
of Chronic Tinnitus and Insomnia with Repetitive Transcranial 
Magnetic Stimulation and Cognitive Behavioral Therapy – a 
Combined Approach. Front Psychol. 2017;8:575. doi:10.3389/ 
fpsyg.2017.00575. 
2. Langguth B, Kreuzer PM, Kleinjung T, DeRidder D. Tinnitus: 
Causes and Clinical Management. Lancet Neurol.  2013;12: 
920. 
 
 
Prediction and prevention of suicidality among patients with depres- 
sive disorders: comorbidity as a risk factor 
Lence Miloseva *1, Vladimir Milosev 1,2, Kneginja Richter 1,3,4, Lukas 
Peter 3, Günter Niklewski 1,3 
1Faculty of Medical Science, Goce Delcev University, Stip, R.Macedonia 
2Clinical Hospital Stip, R. Macedonia 
3University Clinic for Psychiatry and Psychotherapy, Paracelsus Medical 
University, Nuremberg, Germany 
4 Technische Hochschule Nuernberg Georg Simon Ohm 
 
*Correspondence: Prof. Dr. Lence Miloseva, Faculty of Medical 
Science, Goce Delcev University, Stip, Krste Misirkov 10-A, 2000 Stip, 
R.Macedonia; e-mail: lence.miloseva@ugd.edu.mk 
 
Keywords: Prediction, Prevention, Suicidality, Depressive disorders, 
Comorbid disorders 
 
 
Abstract 
The aim of this paper is twofold. The first to assess the role of 
comorbidity as a risk factor in predicting suicidality among pa- 
tients with depressive disorders and those  with  comorbidity  or 
dual diagnosis. The second is to discuss implications for 
prevention. 
Within the framework of the UGD-supported project,  the  data 
were collected from Clinical Hospital, Stip, Macedonia, during 
the period January 2015 to March 2017. The sample consists of 
140 patients (64% female and 36% male) aged 19–72 years. The 
respondents were divided on the basis of mono and comorbid 
diagnosis into four subgroups: 1) those with depressive disorder, 
2) those with depressive disorder and physical illness, 3) those 
with depressive disorder and another mental disorder, and  4) 
those with depressive disorder, physical illness and mental dis- 
order. Data were collected using questionnaires  about 
sociodemographic data, structured interviews and medical docu- 
mentation, while suicidal behavior was studied using the C- 
SSRS scale [1,2]. Written informed consent was obtained from 
all study participants. 
The specific focus was on examining the relationship of suicidal 
thoughts with gender and comorbidity, frequency and intensity, as 
well as differences in preparation, trials, methods and number of 
suicides. Additionally, we examined the characteristics of suicide 
in 46 respondents and whether there was a difference among 
groups in terms of suicidal behavior. The results are in line with 
our expectations, and they show that comorbidity is a significant 
factor in predicting suicidal behavior [3-5]. A detailed statistical 
analysis is reported in the paper. 
Although we are talking about a small sample, at the level of 
absolute numbers and percentages, where comorbidity is a clinical 
reality and suicides are related to the number  of  diagnoses,  a 
larger number of diagnoses leads to a greater risk of suicidal 
behavior. 
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Abstract 
Lamotrigine is  a novel antiepileptic drug metabolised by UGT 
enzymes, mainly UGT1A4 [1,2] and UGT2B7 [2]. Genetic poly- 
morphisms of UGTs result in different phenotypes by affecting the 
expression levels or activity of individual UGT enzymes, hence 
variability in drug metabolism and elimination [3,4,5]. Thus, phar- 
macogenetics is extremely useful in the individualisation of 
lamotrigine drug therapy. Moreover, paediatric populations with 
epilepsy offer a specific challenge in dose individualisation, since 
they undergo significant developmental changes from childhood to 
adulthood [6]. The aim of this study was to investigate the influ- 
ence of genetic polymorphisms of UGT1A4 and UGT2B7 on drug 
concentration in Maltese paediatric patients with epilepsy. 
Blood samples from 18 Maltese paediatric patients were collect- 
ed. Genomic DNA was extracted using well-established standard 
protocols. Primers were designed to span the entire coding se- 
quence of the UGT1A4 and UGT2B7 genes. DNA amplification 
of the specific genes  was performed by PCR on the respective 
patient samples. Gel electrophoresis was used to confirm that the 
desired DNA fragment was obtained. The PCR  products  were 
then purified and sequenced using the Sanger sequencing 
method. 
Various mutations were identified in both genes of interest, lead- 
ing to amino acid changes in the majority of patients. This may 
result in inter-individual variability in the pharmacokinetics of 
lamotrigine. 
This research will lead to improved therapeutic outcomes for paediatric 
populations with epilepsy, by providing a greater understanding of the 
contribution of pharmacogenetics to the individualisation of drug therapy 
and development of personalised medicine. 
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Abstract 
Purpose: The aim of this study is to determine the effects of a physical 
activity program for first-stage Alzheimer's patients with regard to cog- 
nitive function, depression and quality of life. 
Materials and methods: This is single-blinded randomized con- 
trolled trial. The experimental group included 75 Alzheimer's pa- 
tients (40 in the experimental group, 35 in the control group), as 
diagnosed by physicians, who were in the moderate stage of the 
disease (SMMSE score: 23-24) and who were allowed to under- 
take physical activity. An information form including the partici- 
pants' sociodemographic characteristics and medical history, the 
Standardized Mini Mental State Examination (SMMSE), the 
Quality of Life–Alzheimer’s Disease scale (QoL–AD) and Beck 
Depression scale were used for data collection. Statistical analysis 
was performed using SPSS 18.0 (IBM, Armonk, NY, USA). 
Continuous data were presented as medians (interquartile range), 
categorical data as counts and percentages. The researchers used 
descriptive statistics, including numbers, percentages, means and 
standard deviations. 
Results: This study showed that the physical activity program 
improved cognitive function, depression and quality of life 
among first-stage Alzheimer's patients (p<0.05). These results 
suggest that  regular  physical  activity  programs  should  be  used 
in routine practice to  prevent  cognitive  decline and  depression, 
and to the improve quality of life for first-stage Alzheimer's 
patients. 
Conclusion: According to this study's findings, cognitive function, de- 
pression and quality of life among first-stage Alzheimer's patients im- 
proved as a result of a physical activity program. 
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Abstract 
The overall objective of the Systems Medicine of Mitochondrial 
Parkinson’s Disease (SysMedPD, 2017-2021) project is to iden- 
tify novel drug candidates capable of slowing the progression of 
neurodegeneration in the subset of Parkinson’s disease (PD) pa- 
tients with overt mitochondrial dysfunction. Multi-modal pheno- 
typic characterisation of cohorts of monogenic PD patients with 
overt mitochondrial dysfunction  will  be  used  as  an  anchor  for 
the discovery of two extreme cohorts of idiopathic PD patients: 
with and without detectable mitochondrial dysfunction. A suite 
of personalised in vitro, in vivo, and in silico models will be 
generated using induced pluripotent stem cells (iPSCs) from se- 
lected subjects and controls.  An industrial-  quality 3D 
microfluidic cell culture product, specifically designed for the 
culture of iPSC-derived dopaminergic neurons, will  be  devel- 
oped for use in a  morphological  and  bioanalytical  screen  for 
lead compounds in  order  to  reduce  mitochondrial  dysfunction. 
By monitoring motor behaviour and in situ striatal neurochem- 
istry at high temporal resolution, the in vivo response to lead 
compounds will be characterised in humanised  mouse  models 
with striatal  transplants of iPSC-derived dopaminergic neurons 
derived from  PD  patients.  Personalised  computational  models 
of dopaminergic neuronal metabolism and mitochondrial mor- 
phology will be developed. These in silico models will be used 
to accelerate drug development by prioritising pathways for 
metabolomic assay optimisation, stratifying idiopathic PD pa- 
tients by degree of mitochondrial dysfunction, predicting new 
targets for reducing mitochondrial dysfunction and mechanistic 
interpretation of in vitro and in vivo experimental results. 
SysMedPD unites a highly experienced multidisciplinary consor- 
tium in an ambitious project to develop and apply a systems 
biomedicine approach for preclinical identification of candidate 
neuroprotectants, for the estimated 1–2 million people  world- 
wide who suffer from PD with mitochondrial dysfunction. An 
overview of the scientific rationale and main objectives of the 
project  shall  be  presented,  followed  by  preliminary  results  to 
date, particularly with respect to multi-scale mechanistic compu- 
tational modelling of PD and the implications for systems med- 
icine in other complex diseases. 
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Abstract 
Central serous chorioretinopathy (CSCR) is the fourth most com- 
mon retinopathy, typically affecting men in the third and fourth 
decades of life. The disease can be presented in acute or chronic 
form and can lead to decreased visual acuity (VA). Changes most 
often involve the macula, and are associated with pigment epithe- 
lial and neurosensory retinal detachment. Diverse risk factors such 
as the use of glucocorticoids, psychic stress, systemic hyperten- 
sion, use of alcohol, and smoking have been reported in the 
pathophysiology of the disease. Several precise diagnostic tools 
showed that the choroidal blood flow is altered locally in the 
affected eye in CSCR. Our investigations of patients with CSCR 
showed that  CSCR  and Flammer  syndrome  have risk factors in 
common. Patients with Flammer syndrome generally have in- 
creased retinal vein pressure and elevated plasma endothelin-1 
levels. This can be accompanied by choroidal hyperpermeability 
and subretinal fluid accumulation. Flammer Syndrome could be a 
potential risk factor for the development of CSCR. Screening for 
Flammer syndrome among CSCR patients can help us to better 
understand the pathophysiological process of CSCR development, 
and may lead to important discoveries regarding predictive factors 
for this disease. 
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Abstract 
Interleukin-7 receptor-alpha (IL7-Ra) is involved in homeostasis 
of autoreactive T cells in multiple sclerosis (MS). Several studies 
have confirmed an association between the polymorphism 
rs6897932 C/T in the IL-7Ra gene and MS susceptibility. In our 
study, we tried to identify a possible association between this 
polymorphism and the risk of MS along with the rate of disease 
progression in a Slovak population. The rs6897932 polymorphism 
was detected in 219 clinically diagnosed MS patients and 218 
healthy control subjects. We ascertained the Multiple Sclerosis 
Severity Score (MSSS) for each patient, and based on these 
scores, we chose 53 patients with rapidly progressing and 57 
patients with slowly progressing disease. DNA samples were ex- 
tracted from peripheral white blood cells and genotyped by PCR 
and restriction analysis. We found a significantly higher frequency 
of ancestral allele C in MS patients than in controls (p = 0.033). 
We found no significant differences in genotype or allele frequen- 
cies of SNP rs6897932 between the slow- and rapid-progression 
subgroups. Allele C of rs6897932 seems to increase the risk of 
MS development in a Slovak population. We did not confirm an 
association between this gene polymorphism and the rate of MS 
progression. 
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Abstract 
Ataxia is a disorder which presents with varying degrees of loss of control 
of normal bodily movements. Although acquired ataxia may be encoun- 
tered, it is more commonly found as a hereditary condition. A wide array 
of genetic variants have been identified as the cause of each of the mul- 
tiple subtypes of inherited ataxia. Although several members of a Maltese 
family have been diagnosed with hereditary ataxia, little is known about 
the nature of the causative variant/s. The family history suggests an X- 
linked recessive pattern of inheritance. This study undertook the identifi- 
cation and profiling of genetic variant/s causing this disorder in the af- 
fected family members by means of next-generation sequencing using a 
clinical exome panel coupled with bioinformatics analysis. The data are 
presently being followed up by PCR amplification of the identified 
variant/s or gene/s and subsequent Sanger sequencing of the PCR prod- 
uct. Once established, efforts can be made to understand the mechanisms 
underlying the causative variant/s such that a cure, or more likely a symp- 
tomatic treatment, may be provided. Additionally, genetic counselling 
can be provided to guide future generations of this family line with regard 
to aspects of family planning. 
 
 
 
Altered sense regulation and related health conditions: is a predictive 
modelling possible? 
Nadja Koschelew1 and Olga Golubnitschaja*2,3,4 
1CEMBIO, Rheinische Friedrich-Wilhelms-Universität Bonn, Germany 
2Radiological Clinic, Rheinische Friedrich-Wilhelms-Universität Bonn, 
Sigmund-Freud-Str 25, 53105 Bonn, Germany 
3Breast Cancer Research Centre, Rheinische Friedrich-Wilhelms- 
Universität Bonn, Bonn, Germany 
4Centre for Integrated Oncology, Cologne-Bonn, Rheinische Friedrich- 
Wilhelms-Universität Bonn, Bonn, Germany 
 
*Correspondence: Prof. Dr. Olga Golubnitschaja, Radiological Clinic, 
Rheinische Friedrich-Wilhelms-Universität Bonn, Sigmund-Freud-Str 
25, 53105 Bonn, Germany; e.mail: Olga.Golubnitschaja@ukbonn.de 
 
Keywords: Predictive preventive personalised medicine, Sense regula- 
tion, Diabetes, Flammer syndrome, Multi-level diagnostics, Biomarker 
panel 
 
 
Abstract 
Daily entities such as feeling of thirst, pain sensitivity and smell percep- 
tion are generally conditioned by individual genetic set-up and post-ge- 
nomic/epigenetic regulation – strongly influenced by social and environ- 
mental factors. On one hand, an abnormal (substantially deviating from 
the average) sense regulation is basically neglected at the standard level of 
medical care. On the other hand, an accumulated knowledge in the area of 
sense regulation demonstrates its relevance for development and progres- 
sion of severe pathologies. For example, a significantly reduced feeling of 
thirst leading to low water intake results in body dehydration that is a 
well-acknowledged risk factor for breast cancer, amongst others [1]. 
Altered sense regulation attracts attention in both – diabetes mellitus, 
leading to cascaded comorbidities [2], and Flammer syndrome, subopti- 
mal health conditions relevant for several pathologies investigated [3-5] 
(see Fig. 1). 
Thirsty feeling 
Reduced in Flammer syndrome with possible adverse health effects: 
– short-term: dehydration, headache, migraine, mood disturbances, 
amongst others 
– long-term: association with breast cancer and aggressive metastatic 
disease [1,5]; 
Increased in type 2 diabetes mellitus, possibly linked to fatigue, nausea, 
cancer, preeclampsia, hip fractures, nephropathy, coronary heart diseases, 
hypertension, venous thromboembolism, cerebral infarct 
Pain sensitivity 
Increased in Flammer syndrome, possibly linked to multiple sclerosis, 
fibromyalgia, impaired wound healing [4]; 
Decreased in type 2 diabetes mellitus and linked to hypertension, neurop- 
athy, impaired wound healing, amongst others 
Smell perception 
Increased in Flammer syndrome [4]; consequences are currently unclear 
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Decreased in type 2 diabetes mellitus, possibly linked to cognitive im- 
pairments and neurodegenerative processes, also reduced in Alzheimer´s 
disease, Parkinson's disease and multiple sclerosis [2] 
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Fig. 1 Altered sense regulation in Flammer syndrome and Diabetes 
mellitus patients: opposed phenotypes are associated with completely 
different pathological conditions 
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Abstract 
The cost of healthcare in the United States (US) is 50–100% more than 
other developed countries. Indeed, one of its closest neighbors – Cuba – 
achieves an average lifespan equal to the US and lower infant mortality at 
one-tenth the cost. 
California – nicknamed the BGolden State^ for both its 
nineteenth- century gold mining and the color of its landscape – 
would be ranked roughly sixth in the world by GDP. California is 
frequently on the Bcutting edge^ of technology, climate change, 
and social policy. However, it is somewhat schizophrenic regard- 
ing healthcare. 
In medical education, residents are increasingly burdened with 
ensuring maximize reimbursement for hospitals rather than 
learning their  specific medical/surgica l specia lty and 
interacting with patients. Instruction on basic science and clin- 
ical medicine is being supplanted with instruction on enhanc- 
ing the electronic medical record (e.g. maximizing the disease 
process  Bcodes^ for  each  patient)  to  ensure  maximum  
reimbursement. 
Another theme in both California and  the  US  in  general  is  the 
need for physicians to obtain advanced degrees such as the master 
of business administration (MBA) in order to participate in a 
healthcare organization. This highlights the difference between 
administering (i.e. enforcing a system’s rules) and managing (i.e. 
optimizing a system’s outcome), which is  a  fundamental  differ- 
ence between healthcare in the US and in the United  Kingdom 
and elsewhere. 
However, the California state legislature in 2017 has introduced 
the BHealthy California Act^ – a proposal for universal single- 
payer healthcare coverage. In California it appears that legisla- 
tors, no physicians, are playing Bcatch-up^ with the rest of the 
developed world regarding healthcare! 
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Abstract 
The United Nations (UN) estimates that disasters have cost over 1.3 
million lives since 1995: following the 2010 Haiti earthquake, 20,000 
people died each day from lack of basic surgery. To improve survival, 
disaster response (DR) must be on-site in 24 hours – not the current days/ 
weeks of DR agencies (e.g., UN and Red Cross). 
Trauma and stroke centers (TSCs) evolved based on evidence that "24/7" 
immediate treatment dramatically improves morbidity/mortality. Unlike 
DR, TSC equipment/personnel are seamlessly integrated into healthcare 
delivery/education systems. We propose that DR–like TSCs–be integrat- 
ed into healthcare worldwide as disaster response centers (DRCs). A 
DRC includes a mobile operating room (including a car battery- 
powered CT, portable by helicopter) transported anywhere worldwide 
within hours. Telemedicine allows immediate subspecialty medical/ 
surgical guidance; drones optimize utilization (e.g., identify the living 
buried in rubble, optimize resource triage). 
Disasters evoke a humanitarian suspension of political, cultural and so- 
cioeconomic barriers that hinder response to other global crises. The DRC 
concept benefits from input/support by the World Federation of 
Neurosurgical Societies, the American College of Surgeons, UN disaster 
relief agencies, WHO emergency response, Aerospace Medical 
Association, Chilean Health Ministry, among others. Initial DRC sites 
are planned for Iquique (northern Chile) and Peshawar (northwest 
Pakistan). 
This global "mega TSC system", with its multinational staff, will 
improve DR, establish global medical training standards, provide 
universal research platforms, and advance healthcare in develop- 
ing countries. There are political, cultural and socioeconomic ben- 
efits – beyond the healthcare benefits – of integrating DR into the 
ongoing global healthcare system. 
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Abstract 
International co-operation has begun to guide the way that science and tech- 
nical skills may contribute to a new global system of health care. Indeed, the 
trend in new research projects is one of working on a multidisciplinary basis. 
Physicians and scientists realize that collaboration offers a more effective 
approach to medical problems. Transparency in work and behaviour will 
bring colleagues and patients closer together. Quality and behaviour codes 
will be subject of special attention in the medical practice and of research as 
well. Medical law implementation and coaching will contribute to optimal 
medical working conditions. Education of health care workers will prepare 
them for their important roles, supported by continued education. People are 
aware of the need to care about the elements that the earth may be able to 
supply. Some antibiotics may become obsolete and will need to be replaced 
by other medicines. Databases must provide access to a patient’s medical 
history so that treatment can be individually tailored. Personalized, predictive, 
and preventive medicine is now a reality. Importantly, these efforts must all 
ultimately serve humankind through equal and honest distribution of health 
care to everyone. 
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Abstract 
The continuously changing market access landscape affects prescription and 
reimbursement levels of medicines and diagnostics in PPPM. The preoccupa- 
tion on the part of healthcare systems with developing robust cost-containment 
measures results in the emergence of new methods of value assessment, new 
forms of price setting, new customer structures, and changes in reimbursement 
and treatment guidelines. Although these changes facilitate access to existing 
medicines for certain patient groups, they create substantial barriers for new 
pharmaceutical, vaccine and diagnostic market entrants [2,4]. Thus, facing the 
lack of incentives in the early 2000s, several large biopharmaceutical compa- 
nies abandoned antibiotics research and development (R&D) and investment, 
focusing instead on therapeutics in oncology and cardiology. As a 
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consequence, resistance to existing medicines continued to increase, while the 
number of new antibiotics receiving marketing authorization declined [1]. 
This study aims to identify major patient access barriers in PPPM, and to 
understand how innovative companies overcome these market access restric- 
tions. The presenter suggests that there exist a number of ways for producers 
to overcome market access barriers, for example, through early-phase con- 
vergence with key stakeholders, introduction of miscellaneous risk-sharing 
agreements, policy shaping, differentiating value-added services, and 
Btailoring  ^evidence generation to stakeholder requirements. [1,3,4]. 
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Abstract 
Innovative technology to be implemented: 
In personalized medicine, therapeutic intervention should be applied before 
the disease symptoms appear. This requires highly specific and highly 
sensitive biomarker arrays (BM) able to predict disease onset and therapeu- 
tic response [1]. Reliable, multiparametric semi-diagnostic and/or disease- 
predictive biomarker arrays are urgently needed for different diseases to 
improve early diagnosis or for monitoring and improving new and existing 
therapeutic strategies. The employment of biochip technologies for the 
simultaneous measurement of several biomarkers (multiplex assay) is nec- 
essary in biomedicine, since common assays (ELISA, Western blot, etc.) 
allow only the quantification of a single analyte at nano- to picogram levels, 
and are inadequate for quantifying low-abundance biomarkers in a complex 
matrix such as serum, urine or saliva [2]. 
Aim of the institute: 
The proposed project, Christian Doppler – Laboratory for Personalized 
Medicine (CD-PM), is a multidisciplinary and collaborative effort 
aimed at performing innovative and novel research in the field of 
modern molecular diagnostics. The development and application of a 
novel, highly sensitive biochip will significantly enhance knowledge 
about biomarker detection in the early stage of diseases and thus their 
role in predictive medicine. The thinking behind this project includes 
both basic and oriented research, with a concrete commercial 
application. 
Application areas, examples: 
The proposed unique and novel, highly sensitive technique is currently 
being evaluated for the early detection of beta-cell dysfunction (diabetes 
mellitus) [3]. The CD-PM will validate other biomarker candidates al- 
ready identified by key researchers from our cooperative partners. 
PPPM outlook: 
This novel technology has the capacity to significantly improve the sen- 
sitivity and specificity of existing analytical systems from femto to 
attogram levels. Once the assay platform is established, it can be retooled 
for nearly any diagnostic markers by replacing and optimizing the spe- 
cific capture/detection conjugate, because the other components will be 
universal. Peripheral biomarkers for other metabolic disorders are cur- 
rently under evaluation [4]. 
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Abstract 
Background. Antarctica is a unique place to study health conditions 
under the influence of environmental factors on the organism in pure form 
[1]. Medical research in Antarctica opens up new horizons of understand- 
ing across a spectrum of individual health conditions under stress and 
unusual environmental conditions. 
 
EPMA Journal 
 
 
Aim. To analyze and discuss the retrospective medical data of 
long-term monitoring and observations at the Ukrainian 
Akademik Vernadsky Antarctica station and initial data from pro- 
spective studies. 
Methods. We analyzed the multi-scale information of retrospective 
and prospective medical  and  biological  studies,  performed  with 
the participation of all 22 Ukrainian wintering expeditions, based 
on surveys of over 220 men aged 20–60 years (mean  age  37 
years). Extensive medical  examinations were  carried  out  before 
the expedition, during the selection of candidates, and after 
returning, and particular functions were monitored during the en- 
tire stay in Antarctica. Medical records were analyzed to investi- 
gate microbiome, vascular dysfunction, hypoxia, mitochondrial 
dysfunction, and genetic polymorphism (hypoxia-inducible factor 
1 (HIF-1) parameters. 
Results. The examinations showed multi-level symptoms of the process- 
es of dysregulation and dysadaptation, especially during adaptation to the 
Antarctic (1-month stay at the station) and, to a lesser extent, after 
returning from an expedition to Ukraine. A long stay in Antarctica evoked 
adaptive reactions associated with hypoxia and mitochondrial dysfunc- 
tion, determined by a set of molecular-genetic mechanisms that trigger the 
expression of the corresponding genes and alter the mitochondria ultra- 
structure, leading to the death of organelles, and subsequently the cells, 
and are associated with pronounced oxidative stress [data in press]. 
Preliminary microbiome studies in the Antarctic setting have shown an 
increase in fungi on the skin of expedition participants, believed to be due 
to interference with local immunity and dysbiosis of the normal skin 
microbiome due to stress, recycled air, and antiseptic agents [1,2]. This 
region permits the study of conditions such as Flammer syndrome, 
amongst many others. Preliminary analysis demonstrated changes in re- 
sponses on the Flammer syndrome questionnaire [3] carried out before 
and after the expedition; medical examinations showed stress 
dysadaptation via alteration the thyroid, gut function, and pain sensation 
[4]. 
Conclusions. The series of the retrospective and prospective studies dem- 
onstrated the strong influence of extreme environmental factors and stress 
in the absence of man-made factors on health parameters, with clearly 
defined individually patterned reactions. 
The translation of obtained  results  enables  the  determination  of 
the a Bpre-pathology^ condition for patient stratification that have 
a crucial impact on the management of chronic diseases in routine 
life by modifying stress-related conditions such as lifestyle, diet, 
and microbiome. In addition, since the region is essentially sterile, 
it permits unbiased research on the microbiome that may not be 
possible elsewhere. 
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Abstract 
Laboratory medicine is among the essential sources of reliable clinical 
information, providing the basis for objective disease/health assessment 
in individuals [1]. Predictive, preventive and personalized medicine 
(PPPM) emphasizes complex characteristics of health as a phenomenon 
[2]. In this context of complexity, laboratory medicine should not only 
significantly extend the range of tests and markers, but it should also 
significantly expand the range of distinct analyses, reflecting four princi- 
pal categories of factors/materials related to health as outlined previously 
[3]. These principal categories comprise physical, chemical, biological 
and psychosocial factors, each of which can be of an internal and external 
nature. Complex clinical laboratory diagnostics/medicine should analyze 
factors/materials that have a potential impact on health and/or consistently 
reflect changes in health status. All data should then be interlinked with 
the patient’s standard medical record in order to prepare a complex report 
on his/her health/disease state in the context of PPPM (Fig. 1). 
Such an extension of laboratory medicine, effectively supported by so- 
phisticated information technology, will clearly represent a qualitative 
leap in healthcare and, in the long term, have the potential to significantly 
reduce healthcare costs through early prediction that is built on compre- 
hensive, computer-assisted processing of reliable data acquired by com- 
plex analysis of various factors/materials, thus significantly reducing 
health deterioration in each individual. 
The vision of EPMA is to build such a pilot complex clinical laboratory 
dedicated to the personal health assessment of apparently healthy indi- 
viduals [4]. 
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Fig. 1 Four principal categories of external and internal factors and/or materials which extended laboratory medicine, in the context of PPPM, should take 
into consideration when assessing the health of an individual. 
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Abstract 
Health awareness as a concept of health-related knowledge about 
disease prevention and treatment remains underutilized by Russian 
healthcare, whereas the English medical community demonstrates 
a persistent use of communication strategies for health education 
of the population. The objective was to identify communication 
strategies employed by Russian and English medical websites for 
health awareness development. 
Material and methods. Ten official websites of English and Russian 
healthcare organizations and executive bodies were analyzed. Total cor- 
pus (n=78) included English (n=38) and Russian (n=40) texts. 
Contextual, descriptive and qualitative analysis was performed, which 
revealed 3three categories of strategies: informative, imperative, and 
mixed (informative + imperative). 
Results. The English corpus (EC) demonstrated all strategies employed 
by the texts for the general public: informative (32%), imperative (25%), 
mixed (43%). The Russian corpus (RC) demonstrated a predominant use 
of informative strategies (57%) and significantly lower use of imperative 
(18%) and mixed (25%) ones. 
Conclusion. The proportional involvement of all strategies in EC 
determines their effective contribution to the development of 
health awareness; the lower use of imperative and mixed strate- 
gies in RC may be an obstacle to developing health awareness in 
the population. 
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Abstract 
Emergency and limited-resource subsets need sustainable, comprehen- 
sive and reliable diagnostic approaches [1-3]. Emergency physicians with 
imaging expertise can focus on further procedures, skipping time- 
consuming and expensive steps [4-5]. 
Emergency clinical ultrasound, as an adjunct to other reliable bio- 
markers, enables early predictive information, preventive manage- 
ment of impending or worsening conditions, and personalized ther- 
apy. Acute abdominal emergency (appendicitis, small bowel ob- 
struction, gallstones, cholecystitis, aortic aneurysm), and particular- 
ly acute chest disease (pleural-pericardial effusion, pneumonitis, 
pleura-pulmonary consolidation), may present discordant informa- 
tion between ultrasound (US) and chest-X-ray (CXR). An ongoing 
study is addressing some new concepts in clinical and ultrasound 
stratification of respiratory disease in 73 consecutive patients re- 
ferred to the same emergency facility. Key symptoms (dyspnea, 
chest pain, cough), laboratory assays (CRP, total leukocyte and neu- 
trophilic counts) were considered, and the relative odds of finding 
concordant or discordant US and CXR imaging in pleural effusion 
and lung consolidation are displayed. In general, the predictive ac- 
curacy of combined conventional non-imaging clues (symptoms and 
laboratory assays) is insufficient for lung density and pleural effu- 
sion. Accuracy in the detection of pleural effusion is exceedingly 
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higher for US (98.5 vs. 77.5), while the combined use of US and 
CXR, with one and/or both procedures positive, provides greater 
accuracy for lung density detection. 
The implementation of a comprehensive culture of ultrasound imaging in 
medical school curricula and in continuous medical education is a sus- 
tainable advancement for the quality of our emergency departments and 
of the mobile medical units used in rescue activity during disaster or war 
crisis. 
 
References 
 
1. Interrigi MC, Trovato FM, Catalano D, Trovato GM. 
Emergency thoracic ultrasound and clinical risk management. 
Ther Clin Risk Manag. 2017 Feb 9;13:151-160. doi: 10.2147/ 
TCRM.S126770 
2. Sperandeo M, Rea G, Grimaldi MA, Trovato F, Dimitri LM, 
Carnevale V. Contrast-enhanced ultrasound does not discriminate 
between community acquired pneumonia and lung cancer. Thorax. 
2017; 72(2):178-180. doi: 10.1136/thoraxjnl-2016-208913 
3. Trovato FM, Catalano D, Trovato GM. Thoracic ultrasound: An 
adjunctive and valuable imaging tool in emergency, resource- 
limited settings and for a sustainable monitoring of patients. World 
J Radiol. 2016; 8(9):775-784. 
4. Trovato FM, Catalano D. Diagnosis of Pneumonia by Lung 
Ultrasound in Children and Limited Resources Subsets: A Valuable 
Medical Breakthrough. Chest. 2016; 150(1):258-60. doi: 10.1016/j. 
chest.2016.04.032. 
5. Sperandeo M, De Cata A, Molinaro F, Trovato FM, Catalano D, 
Simeone A,Varriale A, Martines GF, Trovato G. Ultrasound signs 
of pulmonary fibrosis in systemic sclerosis as timely indicators for 
chest computed tomography. Scand J Rheumatol. 2015; 44(5):389- 
98. doi: 10.3109/03009742.2015.1011228 
 
 
 
 
 
Fig. 1 Top, right lobar pneumonia (A: x-ray; B: US scan). Bottom, small bowel obstruction (A: CT scan, B : US scan) 
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Abstract 
Background. The human blood group system is a complex protein-based 
system that consists of multiple antigens, including 54 antigens with more 
than 200 different alleles for RHD alone, and 50 different RHCE alleles. 
The five most important antigens from this blood group system are the D, 
C/c and E/e, since they are the cause of most alloimmunity. 
 
Aim. Blood group genotyping is the method of choice when serological 
techniques cannot be used. In order to successfully use techniques such as 
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PCR and DNA sequencing, one must first determine the frequency of said 
blood group antigen genotypes in the Maltese population. Thus far, the 
molecular transfusion group of Malta has investigated the Kidd, 
Cartwright, Colton and the major RHD and RHCE antigens. 
Materials and methods. Four hundred blood donor samples were en- 
rolled in this study. An allele-specific oligonucleotide polymerase chain 
reaction (ASO-PCR) was used to determine the presence of RhD, E and e, 
while multiplex PCR was used to test for RhCc, Cartwright and Colton 
genotypes. PCR RFLP was the method of choice for the Kidd genotypes. 
Results. We present all current molecular data obtained thus far for the 
abovementioned blood group genotypes. In brief, out of 400 donor sam- 
ples studied, the incidence of RhD was 90.75%, and 9.25% were negative 
for the D antigen. The incidence of the other Rh antigens was 76.75% for 
C and 73.75% for c, 25.25% for RhE and 97.75% for Rhe. The most 
common phenotype in RhD-positive samples was CcDee (36.50%), and 
in RhD negative it was ccdee (8%). The Colton Co(a+b-) exhibited the 
highest percentage occurrence (88.23%), whilst the heterozygous form of 
the phenotype, Co(a+b+) demonstrated a lower prevalence (5.88%). 
Co(a-b+) was not encountered in this study. Other data from different 
blood group antigens will also be presented. 
Conclusion. These blood group systems have a vital role in population 
genetic studies and, most importantly, in resolving medical issues in transfu- 
sion practice, thus favouring the personalisation of health care in public health. 
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Abstract 
Kashin–Beck disease (KBD) as an endemic disorder is clinically char- 
acterized by thickened and deformed joints. The etiology of KBD needs 
to be determined. The present report shows epidemiological characteris- 
tics of KBD via cross-sectional survey, national surveillance, case- 
control study, and intervention trial. X-ray images of the right hands of 
school children ages 7–12 were utilized to diagnose new KBD patients 
and disease severity. The national incidence of KBD was 22.1% in 1990, 
16.0% in 1995, 12.3% in 2000, 5.5% in 2005, 0.38% in 2010, and 0.18 
in 2015. In a series of valleys and villages of Tibet, Qinghai, Shaanxi, 
and Inner Mongolia, historical records show KBD prevalence of nearly 
50%. In 2002, there were 819,666 individuals with KBD among 
37,908,700 residents in endemic areas across China. By 2014, 611,187 
patients out of 22,567,600 inhabitants were living in KBD-endemic 
areas. Typical features of KBD include early onset, gender equality, 
agricultural region, and uneven regional distribution. Epidemiological 
data show that KBD is associated with multiple risk factors such as 
fungal contamination of food grains, selenium deficiency, and food pro- 
tein imbalance. Preventive measures include health funding in endemic 
areas, food diversification, food protein consumption, selenium dietary 
supplement, grain exchange, and relocation out of KBD areas. 
Comprehensive measures have been implemented in the prevention of 
KBD for a long period and so far a satisfactory result has been achieved. 
It is entirely possible to eradicate KBD from the earth. 
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Abstract 
Background. Socially significant diseases have their roots in early years 
of life, as consolidation of negative behavioral stereotypes begins in youth 
[1]. 
Objective. To study the dynamics of the main risk factors (RF) in 
students over six years of their training at the medical 
university. 
Materials and methods. Presented prospective analysis of a sample of 
125 students enrolled in the first year in 2011, which was re-examined on 
the sixth course [2]. Fulfilled questionnaire survey aimed at identifying 
RF of type of arterial hypertension (AH)/pre-hypertensive (PH) [3], obe- 
sity, smoking, hypodynamia, and irrational nutrition [4]. 
Results. AH was found in 4.6% of freshmen, including 7.9% of 
boys and 3.4% of girls. It was recorded for 8.0% of graduates, 
with 13.2% of boys and 5.7% of girls. PH with blood pressure of 
130/80 to 139/89 mm Hg was detected in 6.4% of school leavers, 
with 10.5% of boys and 4.6% of girls, and in 15.2% of graduates, 
including 23.6% of boys and 11.4% of girls. Cases of obesity and 
increased body mass index were  identified  in  9.0%  during  the 
first year of study, with 12.9% of boys and 7.7%  of  girls,  and 
22.2% in the sixth year, including 41.8% of boys and 15.5% of 
girls. The presence of physical inactivity was found in 14.8% of 
first-year students, including 9.6% of  boys  and  16.6%  of  girls, 
and id 38.8% of graduates, with 48.3%  of  boys  and  35.5%  of 
girls. Poor nutrition was present in 44.6% of first-year students, 
with 22.5% of boys and 52.2% of girls, and was found in 45.4% 
of graduates, including 48.3% of boys and 44.4% of girls. 
Conclusion. The negative dynamics of  behavioral  and  biological 
RF revealed among students during their study at university ar- 
gues for early establishment of youth health examinations [5], 
which must include relevant preventive educational modules [4]. 
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Abstract 
Background. Poor sleep contributes to the development of stress [1], 
which in turn is recognised as a risk factor for developing cardiovascular 
(CV) pathology [2,3]. 
Objective. Evaluation of sleep and anxiety/depressive disorders (ADD) 
of medical students based on their additional work in hospitals. 
Material and methods. Forty-nine students of five or six courses of 
medical faculty of StGMU were surveyed with a questionnaire regarding 
subjective sleep characteristics (Russian Somnological Centre) using the 
Epworth daytime sleepiness scale, Stanford and Berlin questionnaires, 
and the Hospital Anxiety and Depression Scale (HADS), in order to 
determine the presence of ADD. Students were divided into two groups: 
working students (23) and non-working students (26). Statistical analysis 
was conducted using Microsoft Excel. 
Results. Working students slept on average 6.0 ± 1,1 hours at night, and non- 
working students 7.06 ± 1.2 hours. Severe/moderate daytime drowsiness was 
found in 34% and 65% of students from the working group, but only 7% and 
23% of the non-working group, respectively. Representation of apnea was 
similar between the two groups, but the structural characteristics of sleep 
quality differed significantly. The occurrence of pronounced/borderline values 
of ADD for the working students were 31% and 42%, and among the non- 
working group were 15% and 23%, respectively. 
Conclusion. Additional work among medical students is associated with 
a decline in quality of sleep and development of ADD, which are in turn 
associated with reduced stress resistance. Working students must be in- 
cluded in the cardiovascular risk group [4] for timely implementation of 
preventive measures [5] as part of medical school student health centres. 
The number of such centres in Russia has been steadily increasing. 
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Abstract 
Background. Modern lifestyles promote the development of atherogen- 
esis [1]. Therefore, it is advisable to intensify implementation of diag- 
nostic screening for early vascular ageing (VA) among young men [2]. 
Objective. To identify cases of increased VA in younger men in relation 
to different risk factors (RF). 
Material and methods. Fifty-five boys were examined at the Centre for 
Student Health of StSMU as part of the project "The University – Health 
Area". Analysis was performed on the occurrence of major RF and the 
state of the vascular wall in terms of the cardio-ankle vascular index 
(CAVI) and VA using the VaSera-1500 diagnostic software system 
Fukuda Denshi, Japan). 
Results. The number of boys at the 95th percentile for R-CAVI and L- 
CAVI was 7.1 and 7.2, respectively. Of the 55 students, a CAVI level 
equal to or greater than it appeared was found for six people for R-CAVI 
(10.9%) and seven for CAVI-L 7 (12.7%). These young men differed in 
VA by 40–44 years. One or more RF were found in four of seven boys 
were distinguished. One student was characterised by dysfunction of 
connective tissue (DCT) [3], with the presence of corresponding pheno- 
type, propensity for keloid scars, history of pneumothoraces, and mitral 
valve prolapse. Another young man suffered tonsillitis and pyelonephri- 
tis, and a third student had no RF. 
Conclusion. The introduction of angiologic screening in the process of 
student examination can serve as a complement to traditional screening of 
groups with cardiovascular risk factors [4,5], as early VA can occur in the 
absence of other RF. 
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Abstract 
Iodine deficiency disorders (IDD) have been recognised as a severe pub- 
lic health problem in China since the 1950s. Data recorded in the 1970s 
show 370 million people, and in 1993, 720 million people, at risk of IDD. 
Thirty out of 31 provinces and 1778 of 2835 counties were classified as 
endemic. In 1994, universal salt iodisation (USI) was launched to control 
IDD, and has achieved considerable success. As of 2005, China had 
eliminated IDD nationally [1], with children’s urinary iodine above ade- 
quate and goiter rate of 5%. However, since 2007, 342 new cases of 
cretinism have been found in Xinjiang and other provinces [2]. 
Over the last decade, through the implementation of measures of surveil- 
lance, investigation and evaluation, adjusting iodine content in salt and 
supplying iodised oil pills or free iodized salt, and the establishment of an 
IDD information system, China has maintained sustainable IDD elimina- 
tion on a national basis [3]. The results of a national IDD survey in 2014 
show a goiter rate of 2.6% among children’s, no deficient or excess 
urinary iodine was found among children in all provinces, and the cov- 
erage rate of qualified iodized salt had increased to 91.3%. No new cre- 
tinism cases have emerged since 2010. 
China has built a solid base of working experiences over the 20 years of 
its USI programme, including a mechanism of Bgovernment leadership, 
sectoral collaboration and participation ,^ and a strategy of Blocally appro- 
priate and evidence-based iodine supplementation for various population 
groups^. Evaluations have shown enormous success achieved by China’s 
USI programme in meeting global and national IDD targets [4]. 
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Fig. 1 Surveillance and investigation of IDD in China 
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Abstract 
Natural extracts (plant metabolites, fungi, micro-organisms, etc.) are an 
extremely rich and diverse source of active therapeutic ingredients, or at 
the very least, contribute to preventive health and well-being. A majority 
of our current therapeutics are based on an original natural discovery or 
are still derived from natural sources. New medicine development is 
becoming prohibitively expensive, especially for chronic and rare dis- 
eases, and now, even for common viral and bacterial infections, (multi-)- 
drug resistance is a widely occurring problem. 
Global traditional medicine has maintained centuries of knowledge about 
effective healing with these extracts. Large collections of plants and extracts 
with metabolites have been well-characterized, often with traditional use, but 
beyond initial scientific interest, nothing is done with this knowledge base. 
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However, there are serious challenges to upscaling of production, 
including quality control concerns and inconsistent clinical evi- 
dence, posing difficulties in regulatory registration and obtaining 
market authorization. Lessons learned will be presented from an 
actual rich R& D program that we performed in a bio- 
pharmaceutical company to screen for and further clinically develop 
a therapy against leishmaniasis. 
In fact, Research & Innovation Management Services (RIMS) is now one 
of three founding organizations of a new legal entity behind a European 
research infrastructure platform for natural extract screening with re- 
nowned institutes across Europe (www.euplantcropp.eu), for 
applications in medicine and nutraceuticals (protecting people) and 
agro-biotech (protecting plants). With this new structured approach, and 
with the most modern technologies through an European platform, an 
open discussion with EPMA members on potential targets (and indica- 
tions for which diseases) would be valuable. 
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Abstract 
The Mediterranean diet has been associated with a reduced risk of devel- 
oping major chronic diseases and with mortality [1]. Late evidence sug- 
gests, however, that people from Mediterranean areas are drifting away 
from this traditional diet, and has revealed emerging socioeconomic dis- 
parities in dietary habits even in epidemiological settings characterized by 
a relatively high socioeconomic homogeneity [2]. In this context, the 
economic crisis that started about 10 years ago poses a serious threat that 
the disparities in access to healthy foods will continue to grow. The 
decline in the Mediterranean diet began long ago, but a dramatic drop- 
off has been recorded in the most recent years. Data from the Moli-sani 
study showed that, beginning in 2007, material resources such as house- 
hold income have become a strong determinant of the adherence to the 
Mediterranean diet, whereas they were not associated with diet in earlier 
years [3]. Although the shift was documented among the whole popula- 
tion, the decline is likely to be more evident across vulnerable groups and 
the elderly. 
Indeed, evidence from a recent Italian national survey (INHES 
study) revealed that undesirable dietary modifications possibly 
linked to the current economic crisis were mainly  reported  by 
lower socioeconomic groups, and that subjects perceiving a neg- 
ative impact of the recession on their diet also showed lower 
adherence to the Mediterranean diet and reduced quality of gro- 
cery products. 
In light of this, a fruitful reasoning on the ways to revitalize the 
Mediterranean diet should necessarily deal with two key issues: 
First, the Mediterranean diet has become socioeconomically patterned, 
as had already been established for other quality eating models in non- 
Mediterranean settings, and the prominent role of financial over cul- 
tural resources in determining the adherence to this pattern should be 
taken into account. Second, the current economic crisis represents a 
major health threat for the general population, but in particular for the 
most vulnerable socioeconomic groups, possibly leading to wider gaps 
in terms of risk/protective factors across groups. 
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Abstract 
The mystery of longevity is attracting particular interest in the area of bio- 
medical sciences. Why do some populations live longer and healthier than 
others (see Fig. 1)? Ageing as the antipode to longevity is known as the main 
risk factor for chronic/severe disorders such as impaired wound healing, 
cardiovascular disease, cognitive pathologies, cancer, type 2 diabetes mellitus 
and comorbidities with particularly poor outcomes (e.g. cancer patients with 
diabetic history [1]). Is it possible to slow ageing processes and consequently 
prevent the cascade of related pathologies? In order to reply to the question, it 
is crucial to understand which specific mechanisms are characteristic of lon- 
gevity in contrast to accelerated ageing. 
 Accelerated ageing – definition 
Rapidly decreasing capacity of the human body to effectively defend 
against internal and external damagers (extensive oxidative stress), lead- 
ing to clinical onset of the age-related chronic pathologies 
 Longevity – definition 
Stable capacity to effectively defend against damagers, remaining in ex- 
cellent physical and mental health condition over plenty of life-decades 
 Potential biomarker panels for longevity include markers of lipidome 
(APOE, LPO, CETP), oxidation protection (FOXO3A, SOD, HSP70), 
genetic stability (parp, telomeres), and inflammation (IIS-system, 
DHEAS, SIRT1) [2]. 
 Individualised patient profiles 
Longevity: intact genetic information, mitochondrial stability, active re- 
productive function, efficient detoxification pathways, competent DNA- 
repair machinery, amongst others 
Accelerated ageing: genomic instability, telomere attrition, mitochondrial 
dysfunction, cellular senescence, intercellular communication failure, im- 
paired metabolic pathway [3] 
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Fig. 1 Centenarian/longevity map. Centenarian rate (CR) – number of people who survived to 100 years per 10000 persons alive at 60 years in the 
corresponding region 40 years ago; countries are divided into 2 groups: CR < 25 and CR > 55. Stars – 5 (blue zones) – areas with exceptionally high 
longevity, the populations of which share similar lifestyle and environmental factors [4, 5] 
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Abstract 
The global epidemic of obesity and type 2 diabetes mellitus remains a press- 
ing challenge for the scientific community and health care professionals (1). 
Chronic low-grade inflammation is believed to contribute significantly to the 
pathogenesis of target organ dysfunction/injury (e.g., nephropathy) in these 
conditions (1). Lifestyle interventions (e.g., diet and physical activity) are 
known to exert beneficial effects on glycemic control and general health in 
obese/type 2 diabetic individuals (2). Nonetheless, standard exercise programs 
are strenuous and time-consuming, and thus have low long-term compliance. 
In recent years, there has been a surge of interest in whole-body vibration 
(WBV) as a preventive and/or interventional modality that can be applied to 
populations at risk of obesity/type 2 diabetes and associated sequelae. Indeed, 
utilizing the db/db mouse model of obesity/type 2 diabetes, we recently 
showed beneficial effects of WBV on glycemic status in association with 
changes in several indices of inflammatory response, suggestive of a reduction 
in inflammation (3). Importantly, skewing toward myeloid cell production is 
often observed in chronic inflammation and autoimmune diseases (4). In this 
context, myeloid-to-lymphoid skewing is defined by an increased number of 
granulocyte/macrophage lineage, associated with a decrease in the frequency 
of cells with lymphoid lineage. Thus, our recent studies examined the impact 
of WBV in db/db mice and their db/m controls in the context of assessing 
changes in myeloid and lymphoid cells in the blood, bone marrow, and 
kidney. The results indicate increased myeloid potential associated with 
obesity/type 2 diabetes and a developmental skewing in favor of myeloid 
precursors in diabetic bone marrow. Importantly, WBV altered myeloid 
skewing in blood, kidney, and bone marrow of db/db mice suggestive of 
anti-inflammatory effects. Collectively, our observations are consistent with 
the immunomodulatory capability of WBV. Thus, WBVoffers the promise of 
curtailing inflammation associated with obesity/type 2 diabetes, thereby pos- 
itively influencing the outcome of these disorders. 
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Abstract 
The rising prevalence of metabolic syndrome (MetS), a cluster of cardiomet- 
abolic risk factors predictive of type 2 diabetes, relates largely to increasing 
obesity and sedentary lifestyle, but also to early metabolic life events. The 
objective of the study was to build predictive models of evolution toward 
MetS 8 years later, and to bring new knowledge about this pathological state 
using a multilevel approach in an at-risk population (subjects with low birth 
weight). A case–control study (subjects free from MetS at baseline (n=92 
born small vs. n=76 born adequate for gestational age) was designed within 
the French community-based Haguenau cohort. Serum signatures were de- 
termined and compared at baseline (age 20 years) to determine predictive 
biomarkers using both un-targeted metabolomics and targeted proteomics. 
Individual predictive models were first built using linear logistic regressions 
from the omics datasets and epidemiological data. All data were then inte- 
grated to determine whether multidimensional models improved prediction. 
Univariate statistical analyses enabled the identification of 93 discriminant 
metabolites and 37 proteins between cases and controls at baseline, with 
gender differences. The resulting models based on either four metabolites or 
four proteins showed good performance: 18% misclassification (19% cross- 
validation error rate) vs. 11% misclassification (19% cross-validation), respec- 
tively. Multi-omic data integration improved the performance and robustness 
 
EPMA Journal 
 
 
of the prediction (9% misclassification, 16% cross-validation). Correlation 
analyses also contributed to a better understanding of the role of these bio- 
markers in the pathological processes. These results should provide new tools 
for better stratification of at-risk populations. This project was supported by 
the Fondation Francophone de Recherche sur le Diabète. 
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Abstract 
Metabolic syndrome (MetS) is defined by a cluster of cardiometabolic 
factors including obesity, hypertension, dysglycemia, and dyslipidemia. It 
affects a growing number of persons, in particular older adults often 
suffering from multiple chronic diseases, and its prevalence is now a 
public health challenge. In the context of personalized medicine/nutrition, 
new tools are necessary to bring additional knowledge about MetS etiol- 
ogy, better stratify populations, and customize strategies for prevention. 
A nested case–control study on MetS was designed within the Quebec 
Longitudinal Study on Nutrition and Successful Aging (NuAge). It in- 
cludes 61 cases and 62 controls of similar age (68–82 years), selected 
among the 853 men. Both targeted and un-targeted metabolomic/ 
lipidomic approaches, available within the MetaboHUB French infra- 
structure [1], will be performed on serum samples collected at recruitment 
during 2003–2005 (T1) and 3 years later (T4). Data analysis will be 
performed using reproducible online Galaxy workflows [2]. 
The metabolomic/lipidomic data will be processed to identify specific 
signatures of MetS and its components, and to study their stability over 
time. These data will then be analysed for evaluation of a molecular 
reclassification of the MetS phenotype. Finally, they will be integrated 
with available phenotypic and detailed nutritional data in order to better 
characterize sub-phenotypes (Fig. 1). 
The approach developed here will open a door for a more compre- 
hensive understanding of the metabolic phenotype resulting from the 
complex interplay between intrinsic and extrinsic factors. Thus, this 
project will allow an improved description of MetS-associated char- 
acteristics and will offer new tools for better patient stratification in 
elderly populations. 
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Fig. 1 Description of the overall study strategy. 
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Abstract 
Cardiovascular diseases are the main reason for morbidity and mor- 
tality in diabetic patients, and cardiovascular risk is increased at least 
twofold in men and at least fourfold in women with diabetes com- 
pared to non-diabetic populations. Predictive medicine is of the ut- 
most importance in the clinical care of diabetic patients, since 
predicting cardiovascular risk is essential for modification of risk 
factors aimed at prevention or delay of future cardiovascular events. 
The prediction of cardiovascular risk is a valuable tool within the 
context of patient-centered care, as it includes active participation 
of diabetic patients in the decision-making process, resulting in 
higher compliance with the treatments agreed. However, there are 
differences among the current guidelines of various international au- 
thorities, such as the International Diabetes Federation (IDF), 
European Society of Cardiology (ESC) / European Association for 
Study of Diabetes (EASD), American College of Cardiology (ACC) / 
American Heart Association (AHA), American Diabetes Association 
(ADA), and National Institute for Health and Care Excellence 
(NICE), for the prediction of cardiovascular risk in diabetic patients. 
Furthermore, the clinical use of models with classic risk factors and 
novel biomarkers that would predict cardiovascular risk in diabetic 
patients from various populations with acceptable precision poses a 
challenge. Taking into consideration the global diabetes pandemic 
and its close association with cardiovascular diseases, there is an 
urgent need for streamlining of current guidelines on the prediction 
of cardiovascular risk and its use in clinical practice. 
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Abstract 
Vitamin D plays a pivotal role in functional processes that control immune 
function and mineral metabolism, as well as several chronic conditions [1, 2]. 
Emerging data indicate a possible influence of vitamin D on glucose homeo- 
stasis [3, 4, 5]. This study sought to provide initial information on vitamin D 
status among a Ghanaian population with type 2 diabetes and its association 
with glucose homeostasis. This case–control study was conducted among 118 
patients with clinically diagnosed type 2 diabetes mellitus (T2DM) attending 
diabetic clinic at the Nkawie Government Hospital between October and 
December 2015. One hundred healthy non-diabetics living in Nkawie district 
were selected as controls. Questionnaires were administered to obtain 
sociodemographic data. Venous blood samples were taken from both cases 
and controls to estimate their fasting blood glucose (FBG) and lipid profile by 
spectrophotometry and iPTH and 25(OH)D by enzyme-linked immunosor- 
bent assay (ELISA). Statistical analyses were performed using SPSS 20.0 
software. The average age of the study participants was 58.81 years for cases 
and 57.79 year for controls. Vitamin D deficiency was found in 92.4% of 
T2DM cases and 60.2% of the non-diabetic controls. Vitamin D deficiency 
was not significantly associated with HOMA-β [T2DM: r2 = 0.0209, p = 
0.1338 and Control: r2 = 0.0213, p = 0.2703] and HOMA-IR [T2DM: r2 = 
0.0233, p = 0.1132 and Control: r2 = 0.0214, p = 0.2690] in either the controls 
or cases. These results show that vitamin D deficiency was prevalent in both 
those with and without T2DM. There was no association between vitamin D 
deficiency and insulin resistance among our study population. However, 
vitamin D supplementation in T2DM patients is recommended. 
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Fig. 1 Biochemical and physiological relationship between insulin resistance, T2DM and vitamin D 
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Abstract 
In resent years, plasma homocysteine (Hcy) level has been reported to be 
associated with vascular complications for patients with type 2 diabetes 
mellitus (DM2). In such patients, elevated Hcy levels were associated 
with insulin resistance and nephropathy. 
 Objective 
To investigate the association of hyperhomocysteinemia with macro- and 
microvascular complications in patients with DM2 in a Macedonian 
population. 
 Materials and methods 
In this study, 80 DM2 patients were enrolled for study and were classified 
into two groups: 30 patients with no associated complications (control), 
and 50 patients with complications, with diagnosed CAD. and with 
microalbuminuria. Homocysteine levels and HbA1c were determined in 
both investigated groups. 
 Results 
Hcy levels were significantly higher (p<0.000) in DM2 with complica- 
tions, CAD (p<0.000), and patients with microalbuminuria (p<0.000) 
compared with controls. There was a positive correlation between elevat- 
ed HbA1c (r = 0.475) levels and Hcy concentration in DM2 patients. 
 Conclusion 
The results show that homocysteine levels were higher in patients with micro- 
or macrovascular complications, and they were strongly positive correlated 
with HbA1c. The results also reveal that hyperhomocysteinemia is a risk 
factor in the etiology of vascular complications in DM2 patients. 
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Abstract 
Introduction. It is scientifically proven that pregnant women with 
diabetes mellitus have a high risk of developing periodontal dis- 
eases, but prevention and  treatment is difficult in  this group of 
patients. 
Objective: To investigate and analyze dental status of pregnant women 
with diabetes mellitus, to estimate the effect of individual oral hygiene 
complex on periodontal tissues in this group of patients. 
Materials and methods: A clinical and laboratory examination of the 
oral cavity was carried out among110 patients with different types 
of diabetes mellitus and those without it. Women were randomly 
separated into three groups depending on the proposed complex of 
individual oral hygiene. Patients of groups 1 and 2 were trained in 
cleaning teeth and using extra oral hygiene products. The first group 
used toothpaste with herbal extracts; the second group used tooth- 
paste with herbal extracts, sodium bicarbonate and sodium fluoride. 
The third group continued oral care as always. After 2 weeks the 
results were evaluated. 
Results. The study revealed a correlation between values of dental 
indices in these groups of patients. The highest intensity of caries, 
values of hygiene and periodontal indices were found in women 
with diabetes, especially with type 2 diabetes (TDI: 17.5%, OHI- 
S: 1.67%, PMA: 37.4%). The proposed complexes of individual oral 
hygiene demonstrated their effectiveness in groups 1 and 2. 
Conclusion: The results of the study dictate a need for developing 
schemes of individual oral hygiene complex based on the results 
of a full dental examination, including clinical and laboratory 
research. 
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Abstract 
Transcription factor NF-κB plays a key role in inflammation and is 
also an important regulator of genes involved in coagulation and 
thrombosis. NF-κB is activated by a number of signaling pathways 
that converge, in the majority of cases, at the level of IκB kinase 2 
(IKK2). Our study uses constitutive active IKK2 (caIKK2) in a 
conditional transgene mouse model to mimic chronic inflammation 
specifically in endothelial cells and to test a potential aggravating 
impact on the onset of atherosclerosis. 
Mice bearing inducible, aortic-EC-specific Cre recombinase on an 
ApoE-deficient background were crossed with a strain expressing 
caIKK2 downstream of a loxP-flanked stop cassette and fed a 
cholesterol-rich high-fat diet for 12 weeks. RNA sequencing analysis 
of the aortic transcriptome was performed 10 days after induction of 
Cre recombinase by tamoxifen, before starting the western-type diet, 
and revealed activation of inflammatory networks (involving TNF, 
IFNγ and IL1β), which were accompanied by increased immune cell 
infiltration. Flow cytometric analysis of lymph nodes and splenic 
tissue was used to detect infiltration and activation of B and T cells. 
In summary, we conclude that endothelial NF-κB signaling orches- 
trates immune cell responses within the arterial wall and therefore 
plays an important role in the pathogenesis of atherosclerosis. 
Furthermore, our data indicate that inflammatory endothelial cell ac- 
tivation causes early B-cell and T-cell responses in the pathogenesis 
of atherosclerosis before the occurrence of cholesterol-rich lesions. 
References 
 
1. Hoesel B, Schmid JA. The complexity of NF-kappaB signaling in 
inflammation and cancer. Molecular cancer 2013, 12:86. 
2. Hansson GK, Hermansson A. The immune system in atherosclero- 
sis. Nat Immunol 2011, 12(3):204-212. 
3. Tabas I, Garcia-Cardena G, Owens GK. Recent insights into 
the cellular biology of atherosclerosis. J Cell Biol 2015, 
209(1):13-22. 
4. Mohanta SK, Yin C, Peng L, Srikakulapu P, Bontha V, Hu D, 
Weih F, Weber C, Gerdes N, Habenicht AJ. Artery tertiary lym- 
phoid organs contribute to innate and adaptive immune re- 
sponses in advanced mouse atherosclerosis. Circ Res 2014, 
114(11):1772-1787. 
5. Yin C, Mohanta SK, Srikakulapu P, Weber C, Habenicht AJ. Artery 
Tertiary Lymphoid Organs: Powerhouses of Atherosclerosis 
Immunity. Frontiers in immunology 2016, 7:387 
 
Relationship between single-nucleotide polymorphisms of NOTCH1 
gene target sequence and congenital heart disease 
Dong Li*, Long Ji, Haifeng Hou, Kai Zhu, Qian Wang 
School of Public Health, Taishan Medical University, China 
 
*Correspondence: Prof. Dr. Dong Li, 619 Changcheng Road, Taian, 
271000, China; email: dli@tsmc.edu.cn 
Keywords: Congenital heart disease, single-nucleotide polymorphism, NOTCH1 
 
Abstract 
Objective: This study aimed to evaluate the relationship between the 
target sequence SNPs in a 3′ untranslated region (3′ UTR) of the 
NOTCHI1 gene and susceptibility to congenital heart disease (CHD), 
and to explore the functional role of the NOTCHI1 gene in CHD. 
Methods: Functional SNPs in a NOTCH1 target sequence were screened 
using bioinformatics databases. A case–control study of 350 children 
with CHD and 430 controls was conducted to analyse the association 
between rs6563 SNPs and CHDs. NOTCH1 mild and mutant recombi- 
nant expression vectors were constructed by a luciferase reporter gene 
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Fig. 1 RNA-Seq analysis was performed 10 days after induction of gene expression in aortas of BMX caIKK2 mice. Clustering of cell type-specific genes using 
Ingenuity Pathway Analysis (IPA) revealed massive infiltration of T lymphocytes, macrophages, and B lymphocytes. Also depicted are the number of genes in 
each cell type (A). To get a better molecular understanding of the effect of caIKK2 in ECs, IPA was used to identify canonical pathways (B). BMX caIKK2 KI 
mice were crossed on APOE-deficient background and treated with a western-type diet for 12 weeks. En face preparation of isolated aortas revealed increased 
plaque areas in caIKK2 KI mice (C). Draining lymph nodes of the aortas of caIKK2 KI mice showed increased percentages of CD3+CD4+ and B220+ cells (D). 
 
 
 
system. The effects of relevant miRNA on gene regulatory effects were 
also analysed. 
Results: The allelic or genotypic distributions at the locus of rs6563 
showed statistically significant susceptibility to CHD (odds ratio [OR] = 
1.502, 95% CI: 1.209–1.866, P<0.001). Compared to subjects of G/G 
genotype, individuals with G/A or A/A genotype showed the ORs of 
1.414 (95% CI: 1.047–1.908, P=0.02) and 2.366 (95% CI: 1.430–3.914, 
P<0.001), respectively. miR-3691-3p reduced the luciferase activity of the 
A allele, but had no effect on the activity of the G allele. This result 
indicates that the mutation from G to A enhances the negative regulation 
of miR-3691-3p to NOTCH1, contributing to the development of CHD. 
Conclusions: The polymorphism of rs6563G>A is related to hereditary 
susceptibility to CHD. The mutation of G>A may affect the regulation of 
miR-3691-3p to the NOTCH1 gene and alter CHD susceptibility. 
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Abstract 
Background: Obstructive sleep apnea (OSA) is a sleep disorder character- 
ized by complete or partial upper airflow cessation during sleep, which is 
reported to affect approximately 17% of American adults [1-3]. Although it 
has been widely accepted that OSA is a risk factor for the development of 
hypertension, studies focusing on this topic have revealed inconsistent re- 
sults [2-4]. We aimed to clarify the association between OSA and hyper- 
tension, including essential and medication-resistant hypertension. 
Methods: The Preferred Reporting Items for Systematic Reviews and Meta- 
Analyses (PRISMA) was followed [5]. PubMed and Embase databases were 
used to search for relevant studies published up to December 31, 2016. A 
quantitative approach using meta-analysis was employed to estimate the 
pooled odds ratio (OR) and 95% confidence interval (CI). 
Results: Twenty-six studies with a total of 51,623 participants (28, 314 male/ 
23, 309 female; mean age 51.8 years) met the inclusion criteria and were 
included in this study. Among these, six studies showed a significant associ- 
ation between OSA and resistant hypertension (pooled OR = 2.842, 95% CI 
= 1.703–3.980, P<0.05). In addition, a combination of 20 original studies on 
the association between OSA and essential hypertension presented significant 
results, with pooled ORs of 1.184 (95% CI = 1.093–1.274, P<0.05) for mild 
OSA, 1.316 (95% CI: 1.197–1.433, P<0.05) for moderate OSA and 1.561 
(95% CI: 1.287–1.835, P<0.05) for severe OSA. 
Conclusions: Our findings indicated that OSA is related to an increased risk 
of resistant hypertension. Mild, moderate and severe OSA are associated with 
essential hypertension, which manifests a dose–response relationship. The 
associations are stronger among whites and male OSA patients. 
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Abstract 
Introduction: Cold extremities (cold hypersensitivity in the hands 
and feet, CE) is a common symptom in East Asia, including Korea 
[1, 2]. In Korean medicine, CE is used for pattern identification and 
is believed to be associated with various symptoms and diseases [3, 
4]. This study aimed to investigate whether quality of life (QOL) 
differs depending on the presence or absence of CE. 
Methods: In 2013, a national survey was conducted among the general 
population through a specialized survey institute. Subjects were selected 
randomly using a multistage stratified sampling method based on distri- 
bution by region, gender, and age (95% confidence level, sample error ± 
3.0%). A total of 1101 subjects aged 20–84 years were asked to complete 
a questionnaire evaluating QOL (SF-12) and the extent of cold extremi- 
ties [5]. Multiple regression analysis was used to evaluate the correlation 
between CE and QOL score, with adjustment for age, gender, and body 
mass index (BMI). 
Results: Among participants, 18.6% (n = 208) demonstrated CE and 
72.7% (n = 800) no CE. CE was more prevalent in women than men, 
and those with warm hands and feet had higher BMI than those with cold 
hands and feet, regardless of gender or age. In multiple regression anal- 
ysis, CE showed a significant independent effect on the SF-12 physical 
component summary (β = −0.11, p < 0.001) and mental component 
summary (β = −0.10, p < 0.01) when we adjusted for gender, age, and 
BMI. 
Conclusion: This study showed that CE demonstrated significant inde- 
pendent effects on health-related QOL indicators. 
 
 
References 
 
1. Hur Y-M, Chae JH, Chung KW, Kim JJ, Jeong HU, Kim JW, Seo 
SY, Kim KS: Feeling of Cold Hands and Feet is a Highly Heritable 
Phenotype. Twin Res Hum Genet. 2012;15:166-169. doi: 10.1375/ 
twin.15.2.166 
2. Yoshino T, Katayama K, Munakata K, Horiba Y, Yamaguchi R, Imoto 
S, Miyano S, Watanabe K: Statistical analysis of hie (cold sensation) 
and hiesho (cold disorder) in kampo clinic. Evid Based Complement 
Alternat Med. 2013;398458. doi: 10.1155/2013/398458 
3. Bae KH, Lee JA, Park KH, Yoo JH, Lee Y, Lee S: Cold 
Hypersensitivity in the Hands and Feet May Be Associated with 
 
EPMA Journal 
 
 
Functional Dyspepsia: Results of a Multicenter Survey Study. Evid 
Based Complement Alternat Med. 2016;8948690. doi: 10.1155/ 
2016/8948690 
4. Konieczka  K,  Ritch  R,  Traverso  CE,  Kim  DM,  Kook  MS, 
Gallino A, Golubnitschaja O, Erb C, Reitsamer HA, Kida T 
et al: Flammer syndrome. EPMA J. 2014;5:11. doi: 10.1186/ 
1878-5085-5-11 
5. Ware Jr JE, Kosinski M, Keller SD: A 12-Item Short-Form 
Health Survey: construction of scales and preliminary tests of 
reliability and validity. Med care. 1996;34(3):220-233. 
 
 
 
 
 
Fig. 1 Multiple regression analysis for the association between cold extremities and QOL 
Model 1: unadjusted. Model 2: adjusted for gender and age. Model 3: adjusted for gender, age, body mass index. B, unstandardized regression 
coefficients; SE, standard error of unstandardized coefficients; β, standardized regression coefficients; QOL, quality of life; PCS, SF-12 Physical 
Component Summary; MCS, SF-12 Mental Component Summary. *** p < 0.001; ** p < 0.01 
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Abstract 
Background. Pregnancy can function as a load test for identifying 
women at high cardiovascular (CV) risk [1]. Improvement is 
needed in the system of preclinical diagnosis of CV disorders in 
pregnants [2]. 
Objective. To assess the significance of the parameters of central 
aortic pressure (CAP) and aortic pulse wave in the overall cardiac 
examination of pregnants with respect to preeclampsia (PE). 
Material and methods. A total of 253 pregnant women were surveyed, 
in whom risk factors and CV activity was evaluated using the BPLab 
diagnostic complex (Petr Telegin, Russia) with Vasotens Office software 
[3]. A comparison of central and peripheral pressure made it possible to 
identify various options for hypertension (H) – hidden, false and system- 
ic. The results were processed using Statistica 8.0 software. 
Results. The occurrence of false H was seen in 2.75%, systemic H in 
2.75%, and hidden H in 7.5% of cases. The augmentation index in 
women with hidden H did not differ from those with systemic H. 
The incidence of PE in normotensive women was 0.9%, with sys- 
temic H in 14.3% and hidden H in 10.5%. In patients with false H, 
such cases were generally not encountered. 
Conclusion. The data indicate the feasibility of including an assessment 
of CAP in CV examination protocols for pregnants [4,5]: first, the high 
prognostic value of this index was confirmed, and second, hidden AG 
was discovered more frequently in pregnant women than systemic and 
false forms of pressure buildup. The significance of this problem is evi- 
denced by the increased aortic rigidity and more frequent development of 
PE. 
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Abstract 
Studies are lacking as to whether somatoform vegetative nervous 
system dysfunction (SVNSD) is a premorbid condition for cardiovas- 
cular disease (CVD). The present study involved 259 patients with 
SVNSD and CVD risk factors (RF), mean age 22.8 ± 1.6 years. 
Dispersion mapping of the electrocardiogram was used. A factor 
analysis was carried out using the principal components method. 
The criterion for the adequacy of the Kaiser-Meier-Olkin sample 
was 0.664. The Bartlett sphericity criterion was (χ2 (45) = 826.555, 
p <0.001). Three factors with proper values greater than 1 were ex- 
tracted. The first factor (F1) – metabolic – combined systolic blood 
pressure 0.866, diastolic arterial pressure 0.871, and excess body 
weight and obesity 0.792. The second factor (F2) – psychoemotional 
– combined psychosocial stress 0.855, anxiety 0.827, and depression 
0.868. The third factor (F3) – the prenozological changes in the elec- 
trophysiological state of the myocardium (EPhSM) – combined the 
variables: office heart rate 0.820; the total value of the dispersion 
deviations from the norm after an exercise load of 0.434. The dura- 
tion of RRNN after 4 minutes of orthostasis was −0.869; the total 
value of the dispersion deviations from the norm after 4 minutes of 
orthostasis was 0.576. Factor analysis made it possible to establish 
biopsychosocial interrelationships among the psychosocial, biologi- 
cal RF of the CVD and the EPhSM. 
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Abstract 
 Background. It is well known that a standard lipid profile measures total 
cholesterol, triglycerides, and HDL cholesterol (HDL-c), while LDL cho- 
lesterol is estimated. Subtracting HDL-c from total cholesterol, we can 
measure the amount of cholesterol carried by all lipoproteins except 
HDL. This simple math will give the amount of non-HDL cholesterol 
(non-HDL-c) within all atherogenic lipoproteins. However, although it is 
so easy, biochemical laboratories rarely report the value of non-HDL-c. 
 Aim of the study. The aim of our study is to highlight the results of several 
studies that clearly establish the clinical use of non–HDL cholesterol as a 
common predictor of blood lipid patterns associated with increased risk of 
heart disease. 
Material. Recent literary evidence and clinical studies. 
 
 Results. The most important document regarding non-HDL-c was deliv- 
ered by the National Cholesterol Education Program Adult Treatment 
Panel III, where non–HDL-c was highlighted as a key secondary goal of 
therapy in lipid treatment and lipoprotein management. Other studies sug- 
gest that non-HDL-c shows a better correlation with small dense LDL 
particles than do other lipid parameters, including LDL-c. The treatment 
goal for non-HDL-c is usually 30 mg/dL above the LDL-c treatment target. 
 Conclusion. Knowing that non–HDL-c is superior to LDL-c for the pre- 
diction of cardiovascular events, it is very important for each clinical 
chemistry laboratory to report non–HDL-c as a part of routine lipid status, 
with no added expense. Doctors could use it for optimal prevention of 
atherosclerosis and cardiovascular disease. 
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Abstract 
Introduction: Hypertensive nephropathy (HN) is a medical condition 
characterized by damage to the kidney due to chronic high blood pressure, 
and it is second common cause of end-stage renal disease. Podocytopathies 
have a role in pathogenesis of HN, thus the podocyte proteins may have 
significance in early detection of disease. The purpose of this paper is to test 
the significance of nephrin as a marker for early detection of HN. 
Material and methods: This study included 64 people with chronic hy- 
pertension (CH; 33 male/31 female) with an average age of 54.1 ± 5.1 
years. Thirty healthy subjects (10 male/20 female) with an average age of 
48.7 ± 9.4 years were included as a control group. All patients were divided 
into three groups: patients with normoalbuminuria, microalbuminuria and 
macroalbuminuria, according to urinary microalbumin/creatinine ratios. As 
material, we used fresh urine and venous blood. In urine we measured 
nephrin by the ELISA method, creatinine photometrically and 
microalbumin turbidimetrically. In blood we measured urea, creatinine, 
albumin and total protein using a photometric method. 
Results: In 69.7% of normoalbuminuric subjects with CH, we found 
elevated urinary nephrin. Nephrin was significantly elevated in all groups 
of participants with HN compared with the control group (p<0.05). 
Nephrin was significantly elevated in patients with normoalbuminuria 
compared with the control group (p<0.05). We found a positive correla- 
tion between urinary concentration of nephrin and serum creatinine and a 
negative correlation between urinary nephrin and eGFR. 
Conclusion: Nephrin can be a useful marker for early and non-invasive 
detection of HN. 
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Abstract 
The scientific literature suggests that tear biomarkers can be used as a 
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guide towards clinical diagnosis of human health [1]. This study will 
investigate whether tear biomarkers represent a research and clinical op- 
portunity to assess human health prior to, during, and after exposure to the 
spaceflight environment. The focus of this study is to compare bio- 
markers previously identified as potentially relevant to both ocular and 
brain health against unique physiological outcomes of exposure to the 
spaceflight environment. 
Study subjects suffering from terrestrial conditions thought to be similar 
to spaceflight-associated neuro-ocular syndrome (SANS: formerly VIIP), 
e.g. patients with idiopathic intracranial hypertension (IIH) and optic 
neuritis, may be relevant to conditions associated with spaceflight. This 
study will review methodologies, tear biomarkers related to the state of 
ocular and brain health, and the strengths and weakness of using tear fluid 
biomarkers versus other body fluid samples, and will survey current tear 
fluid biomarker knowledge in research and clinical practice. 
A strength of using tear biomarkers is that sampling is non-invasive and is 
used as a guide in understanding pathologies, including ocular and sys- 
temic inflammatory conditions [2]. Moreover, tear biomarkers may re- 
flect diseases affecting the central nervous system (CNS) [3]. For exam- 
ple, in multiple sclerosis (MS), the concordance rate between tear bio- 
markers and cerebrospinal fluid (CSF) is approximately 83%, indicating 
that in the majority of cases, tears are at least as effective as CSF in 
potentially identifying novel MS biomarkers [4]. 
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Abstract 
Impression cytology (IC) is a method which has been used to assess ocular 
surface cells from patients, e.g. conjunctival and corneal epithelial cells. IC is 
a minimally invasive technique which utilises biopore, cellulose acetate or 
polyethersulfone (PES) filters to sample cells, and has traditionally been used 
to ascertain morphological changes to aid in the diagnosis of squamous 
metaplasia and dry eye disease (DED).1,2 
More recently, IC has been utilised for the investigation of gene expression 
of ocular surface cells.3 We demonstrate the use of IC to identify gene and 
protein expression changes between DED subjects and healthy controls 
(HC). 
Conjunctival epithelial cells from DED patients (n=8) and HC (n=7) were 
harvested by IC using the Eyeprim™ device. Quantitative PCR (qPCR) was 
performed to quantify differences in target gene expression: p38-α, IL-1β, 
IL-8, MCP-1 and MMP-9. In addition, the spatial localisation of proteins 
p38-α and phospho p38 were probed in immunofluorescence assays. 
Using the Eyeprim device, the average yield of conjunctival epithelial cells 
(CEC) retrieved was 1.1 x 105 cells/mm2. qPCR analysis demonstrated sig- 
nificantly higher p38-α, IL-1β, IL-8, MCP-1 (all p<0.0001) and MMP-9 
(p<0.002) expression in CE from DED patients versus HC. 
Immunofluorescence studies significantly increased p38-α and phospho 
p38-α protein levels in DED subjects versus HC (p<0.0001 and p<0.01, 
respectively). 
As IC retrieval procedures have improved and the sensitivity of detection 
has increased,4  gene and protein analysis of IC-retrieved CEC may be 
used to identify novel biomarkers of ocular surface diseases. 
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Fig 1. H & E staining of normal human conjunctival cells following IC (Eyeprim® membrane), where (A) shows overall coverage with normal human 
conjunctival cells and (B) shows the magnified structure of conjunctival cells. 
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Abstract 
Omics and systems biology have driven the rapid development of predic- 
tive, preventive, and personalized medicine (PPPM). Variations exist in 
the entire process of healthcare. Extensive genomic, transcriptomic, 
peptidomic, proteomic, and metabolomic data have been achieved in 
the field of human omics. Of these, proteomic variations are the final 
presentation of the genomic and transcriptomic variations. Metabolomic 
variations are the comprehensive results originating from proteins, 
nucleic acids, sugars, and lipids. Proteins and metabolites are two essen- 
tial elements to differentiate the phenotypes. Moreover, many aspects in 
the proteome including splicing, post-translational modifications, trans- 
location, conformation, redistributions, and variants, and in metabolome 
including entire component of metabolites, pattern variations, and 
disease-specific metabolomic variations, remain unknown. Clarification 
of variations in the phenome is a key step toward realizing PPPM prac- 
tice. Proteome and metabolome are important components that contribute 
to the phenome. Therefore, studies of variations in proteomes and 
metabolomes have important scientific value in PPPM, including resolu- 
tion of disease molecular mechanisms, determination of effective and 
reliable biomarkers for personalized prediction/prevention, diagnosis/ 
therapy, and prognostic assessment, and discovery of effective therapeutic 
targets to achieve precision medicine. 
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Abstract 
IgG N-glycan profiles can serve as dynamic indicators of  the 
ageing process and are able to discriminate between normal and 
accelerated ageing by highlighting a discrepancy between a 
body’s age in years of life (chronological age)  and  its  age  in 
terms of health status (biological age). Therefore, IgG N- 
glycome represents a real-time indicator of the interaction  be- 
tween genetic/epigenetic predisposition and the environment. IgG 
N-glycans serve as predictive biomarkers when health is evaluated 
in the context of age, based on the proposition that specific IgG 
N-glycans i) identify variations in responses to maturation, age- 
ing, and environment across the life course at a population level; 
ii) facilitate early risk prediction of chronic disease development; 
and iii) serve as prognostic indicators for the benefit of targeted 
preventive and disease treatment interventions. A new challenge, 
the ability to develop an Bageing biomarker kit^ to be used in a 
(pre)clinical  setting  as  a  tool  of  predictive,  preventive  and 
personalised medicine, is presented here. 
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Abstract 
Nondegradable metallic and polymeric implants are used as mainstream 
solutions in regenerative medicine. Chronic inflammation is the most 
common complication leading to implant intolerance and failure. Key 
cells that control local inflammation and foreign body response are tissue 
macrophages (1). After implantation, macrophages induce acute inflam- 
matory reactions to trauma and foreign material, which must be followed 
by the resolution of inflammation, wound healing phase and restoration 
of homeostasis. Personalized therapeutic solutions are required to im- 
prove implant integration and acceptance. Macrophages are highly plastic 
cells that define the reactions of the immediate tissue microenvironment 
to the implanted material. However, frustrated phagocytosis and inability 
of macrophages to resolve inflammation and restore tissue-specific ho- 
meostatic balance can lead to the chronic inflammation around implants. 
The prevention of implant-induced chronic inflammation by program- 
ming of the macrophage phenotype is a promising strategy for improving 
implant acceptance. The aims of such programming include controlling 
the phenotype of local macrophages by long-term fixation of their healing 
activities and suppression of inflammatory reactions. We have developed 
a cytokine cocktail formula (M2Ct) that induces a stable M2-type pheno- 
type in human primary macrophages characterized by significant suppres- 
sion of induced pro-inflammatory reactions and increased secretion of 
anti-inflammatory cytokines (M2Ct) (2). The positive effect of the 
M2Ct was demonstrated in an in vitro wound healing model. Using this 
model for induction of inflammation by LPS, we demonstrated that the 
M2Ct phenotype was stable for at least 12 days. However, in the absence 
of M2Ct components in the medium, macrophages underwent rapid pro- 
inflammatory reprogramming upon IFNg stimulation. In order to over- 
come the plasticity of macrophages and stabilize their phenotype, for 
direct application of this cocktail on implants and in tissue engineering 
in vivo, the loading and release of the cytokine cocktail from a self- 
standing, transferable gelatin/tyraminated hyaluronic acid based release 
system was developed. The cytokine cocktail demonstrated its anti- 
inflammatory activity in controlled-release conditions. Our data suggest 
that the direct application of a potent M2-inducing cytokine cocktail in a 
transferable release system can be used as a personalized solution to 
improve the long-term acceptance of implanted materials. 
Funding: EU FP7 for research and technological development and dem- 
onstration (Grant number 606294, IMMODGEL). 
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Abstract 
 Main phas es of the physiolog ic wound heali ng  (WH) are the  
Bearly wound^ (hemostasis characterised by fibrin clot formation, 
bleeding stop- page and creation of the hypoxic microenvironment) 
followed by the inflammatory phase well controlled by the wound 
healing mechanisms. That proceeds into the Blate wound^ featuring 
the proliferative phase comprising stem cell recruitment, 
angiogenesis/neovascularisation and wound contraction, followed by 
tissue remodelling and scar formation, finalising the physiologic WH 
[1]. 
 Major players in the physiologic WH are the cellular stakeholders oper- 
ating the repair processes, namely platelets, DECTs, neutrophils, macro- 
phages, T lymphocytes, fibroblasts, myofibroblasts, keratinocytes, epi- 
thelial cells, endothelial cells, endothelial progenitor cells, stem cells, 
peripheral neurons, and extracellular matrix [2]. 
 Pote nti al biomar ker pane ls  includes growth factors (PDFGF,  
VEGF, TGF-ß, FGF protein core, EGF, IGF), cytokines/chemokines 
and tran- scription factors (IL-1, IL-6, TNF-α, IL-10, IL-4, IL-13, SDF-
1α, HIF-1), 
neuropeptides (substance P, NGF, NPY, CGRP), matrix-proteases/inhib- 
itors (MMPs/TIMPs), hormones and nutrients, amongst others [3, 4]. 
 Impaired WH leads to post-surgical complications frequently observed in 
the elderly, chronic ulcers in diabetic patients, hindered and ineffective 
pain management, etc. However, these well-acknowledged examples are 
just the Btip of the iceberg^. The entire spectrum of potential conse- 
quences of the impaired WH is much mor broader, further extended by 
the chronic inflammation and cell/tissue transformation processes causing 
tissue dysfunction and calcification as well as (neuro)degeneration, pro- 
gressive formation of pre/cancerous lesions and pre-metastatic niches. 
That is a subject for predictive diagnostics, targeted prevention and 
personalised medical approaches [5]. 
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Abstract 
Physiologic wound healing (WH) is a well-controlled, highly orchestrated 
process involved in numerous ordinary (sporadic finger cut during meal 
preparation, regular manicure, etc.) and extraordinary (e.g. acute or planned 
surgery) conditions. WH is life-important. Physiologic WH is initiated by 
tissue injury and resolved within a reasonable time frame by the restoration 
of tissue integrity. The entire process follows the essential sequence of 
attributed phases: hemostasis, inflammation, proliferation, and tissue re- 
modelling (Fig. 1) [1]. In contrast, impaired WH is characterised by low 
quality of phase-performance, stagnation (such as chronic inflammation), 
prolonged WH process or even non-healing wounds [2]. The quality of WH 
is highly individual, resulting from both non-modifiable (genetic predispo- 
sition, age) and modifiable (e.g. nutrition, lifestyle, preventable collateral 
pathologies such as type 2 diabetes) risk factors. Contextually, the quality of 
WH is considered n essential parameter in individualised patient profiling 
and the subject for advanced approaches by systems medicine, predictive 
diagnostics, targeted preventive measures, and treatments tailored to the 
person – altogether innovative approaches by predictive, preventive and 
personalised medicine as the Bmedicine of the future .^ For that, multi- 
level diagnostics utilising comprehensive biomarker panels is proposed. 
The potential application is multifaceted: early diagnosis of related pathol- 
ogies and disease predisposition, effective prevention and treatment of col- 
lateral pathologies, prediction and prognosis of post-surgical complications, 
improved individual outcomes in plastic surgery, amongst others [3]. 
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Fig. 1 The process of WH is characterised by an essential sequence of attributed phases; however, the quality of WH is highly individual 
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Abstract 
Multi-omics of saliva is garnering exponentially increasing attention 
as a preferred non-invasive diagnostic tool considered for a spec- 
trum of health conditions, with strong potential for clinical utility. 
However, the association between specific patient profile and saliva 
components (omics signature) should be well understood [1]. Due to 
the complexity of its components deriving from different sources, 
whole saliva is particularly attractive for the biomarker set-up, 
reflecting systematic diseases such as cancer and metabolic syn- 
drome [2,3]. The use of saliva for early and predictive diagnostics 
demonstrates many advantages, such as simple collection, which 
can be easily performed by non-specialised medical units or even 
by patients at home. Saliva collection is a non-invasive approach, in 
contrast to drawing blood or biopsies; it is inexpensive and presents 
no potential health adverse effects typical for any invasive sampling 
and/or radiological approaches utilised for molecular profiling such 
as magnetic resonance spectroscopy [4]. 
 Multi-omics of saliva is a diagnostic tool based on the proteome, 
transcriptome, micro-RNA, metabolome, and microbiome, which is 
utilised in many biomedical fields. Recent advances have broadened 
the salivary diagnostic approach from the oral cavity to the whole 
physiological system, and thus point towards a promising future of 
salivary diagnostics for personalized individual medicine applica- 
tions, including clinical decisions and post-treatment outcome pre- 
diction [5]. 
 Biomarker p anels created for specific diagnostic purposes include 
markers of periodontitis (SNPs), smoking (NGAL, CF058), oral carcino- 
mas (TSCC), orthodontically induced inflammatory root resorption 
(DMP1, DSP, DPP), pancreatic cancer (KRAS, MBD3L2, ACRV, 
DPM1), and gastric cancer (CSTB, CSTB, CSTB) [1-5]. 
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Abstract 
The problem of endoscopic hemostasis merits a special place in the treat- 
ment of gastroduodenal bleeding [1]. 
We conducted a pilot study in 27 dogs, in which we caused two 
bleeding stomach ulcers in each animal (one was pilot, the other 
was control). In 15 pilot ulcers, hemostasis was performed with 
Asepticob-D insufflations in combination with Zhelplastan. In 12 
pilot ulcers the bleeding was stopped with Asepticob-A and 
platelet-rich plasma [2]. Endoscopic treatment of the control ul- 
cers was not exposed. The results of the study were evaluated 
according to the following criteria: hemostasis time, re-hemor- 
rhages, defects healing time. 
The experiments showed that in the pilot ulcers, hemostasis occurred in 
3.92 ± 0.32 s (p<0.01). However, there were no re-hemorrhages. In the 
control ulcers, spontaneous bleeding occurred in 27.46 ± 1.12 s (p<0.01), 
and there were four episodes of re-hemorrhage. The pilot ulcers were 
healed in 8. 6± 0.18 days (p<0.01), the controls in 15.50 ± 0.31days 
(p<0.01). 
Conclusion: Granular sorbents in combination with hemostatic agents 
perform three functions: permanent hemostasis, re-hemorrhage preven- 
tion, reparative regeneration acceleration. 
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Abstract 
The problem of symptomatic erosive or ulcerative gastroduodenal bleed- 
ing in patients with therapeutic pathology is very relevant now [1]. 
We developed a curative program for prevention of gastroduodenal bleeding in 
patients with therapeutic pathology. This program is based on a multidisciplin- 
ary approach, diagnostic algorithm improvement, early preclinical endoscopic 
diagnosis on the second to third day, and well-timed administration of innova- 
tive technologies in local preventive treatment of symptomatic gastroduodenal 
erosions and ulcers with biologically active granular sorbents. A total of 144 
patients with somatic pathology were involved in the clinical study. The patients 
were treated in a multi-field inpatient department and had signs of acute ero- 
sions and gastroduodenal ulcers. Clinical observations showed that early diag- 
nosis by therapeutic endoscopy helped to reveal acute gastroduodenal erosions 
and ulcers without bleeding in 70.7% of patients (p<0.05). The well-timed local 
treatment of acute gastroduodenal erosions and ulcers with the help of biolog- 
ically active granular sorbents enabled the prevention of hemorrhagic compli- 
cations and extra operations, with threefold lower mortality. 
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Abstract 
Lipodystrophy or panniculopathy (edematous fibrosclerotic panniculopathy), 
often called cellulite, is a dimpling appearance of the skin that can lower 
quality of life in many individuals, especially the female populations. 
Reliable and objective diagnosis of the stage (degree) of panniculopathy is 
difficult, since methods such as the Nürnberger-Müller or Elson scales are not 
very accurate and are subjective. The more advanced techniques such as 
high-frequency ultrasonography, ultrasound elastography or photometric 
measurements are also not well adapted for diagnosing this skin condition. 
We propose exploiting thermal imaging for cellulite diagnosis and mon- 
itoring of anti-cellulite therapy. The superficial skin temperature is influ- 
enced by many factors, among them changes in the microcirculation, as 
well as uneven fat cell and water distribution. 
The study was performed using a database of 100 thermal images of female 
volunteers, aged 19–22, with different stages of cellulite, first diagnosed by 
the Nürnberger-Müller scale. The study was conducted with the approval of 
the Senate Ethics Committee for Scientific Research at the University School 
of Physical Education in Wrocław. All recommendations of the European 
Association of Thermology for thermographic measurements in medical ap- 
plications, including preparation of the attendees, exclusion criteria, environ- 
mental conditions and imaging system operational requirements, were strictly 
followed. A thermal image of the back thigh of each volunteer was recorded 
using a FLIR T335 thermographic camera.Next, all thermal images were 
analyzed using software specially developed by our group, called 
ThermaAnalyzer 2.0. This software allows one to determine the number 
and total area of skin irregularities, as well as the distribution in the examined 
region of interest (ROI). Asymmetrical and inhomogeneous superficial tem- 
perature distribution, seen as spots of different sizes and shapes on the thermal 
image, was observed in persons suffering from cellulite. Using quantitative 
parameters including total area of the blemishes and the extent of the area of 
irregularities on the thermal image enabled diagnosis of the cellulite stage with 
more than 80% accuracy. Thus, computer-aided thermal imaging analysis 
provides an objective method of diagnosis and monitoring of therapy results. 
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Abstract 
Cardiotocography (CTG) is used during pregnancy to monitor fetal well- 
being. It enables early detection of fetal distress by monitoring the fetal 
heartbeat along with uterine contractions. More advanced systems record 
fetal movements as well. Diagnosis by means of CTG is usually per- 
formed only in the third trimester, mainly in stationary health care centers 
(hospitals, ambulatory units or well-equipped private practices). Thus, 
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pregnant women are required to travel to the corresponding location, and 
wait for the test and then the diagnosis. 
In the case of high-risk pregnancy, CTG is a very useful diagnostics tool. 
An abnormal CTG indicates serious abnormalities, and in late pregnancy 
may lead to emergency caesarian section. However, even in low-risk preg- 
nancy, it gives the comfort of the proper fetal care what undoubtedly influ- 
ences a well-being of a future mother. There are some attempts to allow the 
in situ CTG diagnosis without the necessity to visit health care unit. 
Here, we report on an innovative integrated device based on a microprocessor 
and a dedicated operating system for in-home use by pregnant women. GSM/ 
GPRS/3G-based communication enables a territorially almost unlimited CTG 
signal transfer from the woman to the telecare center. 
The pregnant woman is instructed by the doctor or nurse on how to use 
the device and how to transmit the recordings. She then receives the 
recorded signals in the form of diagrams, along with explanations relating 
to the fetal heart rate, fetal movements, mother's HR, and warning of (if 
present) decelerations, signal variability, etc. She is also instructed what to 
do, and in the case of emergency, she can be transferred to the nearest 
hospital as quickly as possible. 
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Fig. 1 Exemplary CTG diagrams received by pregnant women after sending the recorded signals to the telemonitoring center 
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Abstract 
Clinical dentistry continues to rely heavily on traditional restorative ap- 
proaches and biomaterials to treat/replace damaged and diseased teeth 
and the periodontium. More recently, implant dentistry has also made 
major strides in techniques for replacement of missing teeth. 
Importantly, the recognition of the pivotal role of stem cells in tissue 
repair and regeneration has led to intense research to identify tooth- 
derived stem cells. Studies have subsequently shown not only the ability 
of tooth-derived stem cells to generate various components of the tooth 
and periodontal structures, but also their utility in regenerative medicine, 
as exemplified by the generation of cells of organs such as the heart, liver 
and brain. More recent studies have demonstrated (functional) tooth re- 
generation in animal models that display physical properties seemingly 
similar to those of natural teeth. Even more exciting is the advent of 
induced pluripotent stem cells (iPSCs) which, similar to embryonic stem 
cells, have the hallmark feature of differentiation to cells of the three germ 
layers; iPSCs make it feasible to generate epithelial and mesenchymal 
stem cells for eventual in vitro generation of a tooth bud, followed by 
implantation into the tooth socket. Since the creation of iPSCs requires 
the use of somatic cells, investigators have explored the possibility of 
using integration-free human urine-induced pluripotent stem cells for 
tooth regeneration. Clearly, this approach has the potential to ultimately 
lead to Bcustom-making^ of tooth and supporting structures, thereby 
bringing true meaning to the term Bpersonalized dentistry .^ Other highly 
relevant research areas involve the identification of growth factors and 
delivery options as well as scaffolding material that would be most con- 
ducive to tooth regeneration. These aspects and their relevance to PPPM 
are the focus of this presentation. 
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Abstract 
Objectives. We hypothesized was that differences in culture and oral 
health care system in Estonia and Vietnam might have an impact on 
dental health (dmft+DMFT) and dental fear and anxiety (DFA) in chil- 
dren of the two countries. The aim of this study was to compare dental 
fear and anxiety (DFA) in relation to dental health between Estonian and 
Vietnamese schoolchildren using the modified Dental Subscale of the 
Children's Fear Survey Schedule (MCFSS-DS). 
Methods. Among a total of 900 schoolchildren 8 to 10 years of age, 344 
from Estonia and 556 from Vietnam agreed to participate in this study. 
Dental health was recorded based on dental caries experience index of mixed 
dentition (dmft+DMFT). DFA was measured using the MCFSS-DS with 
five Likert-scale response options (1 = not afraid at all, 5 = very afraid). 
Results. The mean dmft+DMFT score in Estonian and Vietnamese 
schoolchildren was 5.2 ± 3.1 and 4.1 ± 3.2, respectively. The mean score 
of 11 fear items among Vietnamese children (20.8 ± 9.1) was significantly 
higher than that of Estonian children (15.4 ± 4.4). The prevalence of high 
DFA in Estonian schoolchildren (30.7%) was statistical equivalent to that 
of Vietnamese schoolchildren (28.0%, p>0.05). 
Conclusion. There were significant differences in DFA between Estonian 
and Vietnamese schoolchildren. Differences in oral health care systems 
between the two countries might be considered as a factor affecting dental 
health and DFA among schoolchildren. 
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Abstract 
 Relevance. The success of dental treatment depends both on the profes- 
sionalism of the dentist and on the patient’s compliance with the doctor’s 
medical recommendations [1]. One of the important factors of compli- 
ance is the attitude of patients toward their own dental health [2,3]. 
 Methods. The study involved 136 people aged 18 to 60 years. Methods of 
diagnosis: "Health Attitude" by R.A. Berezovskaya, Questionnaire on the 
relationship to dental health. 
 Results. Among respondents, 34% defined "dental health" as a good 
physical or mental health, and 16% as a lack of disease. Most patients 
assessed their dental health as an average of 63.5 points out of 100, while 
75% of respondents indicated that they needed dental treatment. 
Respondents aged 30–39 years (67 points) rated their health the best. A 
total of 37% of respondents noted that they did not visit the dentist because 
of high prices for services, and 21% because they were afraid of dentists. 
Respondents noted that in health, they relied more on the opinions of 
doctors and less on the media. Among patients, 42% across different ages 
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preferred the empathic, non-referential type of doctor. A doctor of this type 
listens to the patient, builds partnerships, and discusses treatment strate- 
gies with the patient. Most patients (65%) preferred a female dentist. 
 Findings. The majority of respondents noted that dental health was im- 
portant and they needed treatment, but they postponed it. Patients pre- 
ferred a doctor who discussed the course of treatment. 
 Conclusion. The study revealed the need to develop a plan for individual 
approaches for patients of different age groups. 
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Abstract In this article, the psychological characteristics of dental pa- 
tients with periodontal disease are summarized, along with a description 
of patients with positive and negative dynamics of treatment. 
 Objective: To identify relationships between the characteristics of a pa- 
tient’s personality and their implementation of dentist recommendations. 
 Materials and metho ds: Forty-five patients were surveyed, with an average 
age of 43 years. The following psycho-diagnostic methods were used: 1) a 
multidimensional questionnaire on health; 2) the "Diagnosis of interperson- 
al relationships" test; 3) Questionnaire characterological Leonhard– 
Shmishek; 4) individual-typological questionnaire Sobchik L.N.; 5) ques- 
tionnaire of self-evaluation status; and 6) Behterevsky Institute Personality 
Inventory. The following dental indexes of oral health were measured: 1) 
CPITN, 2) PMA, 3) Saxer–Muhlemann, 4) Silness–Loe, and 5) OHI-S. 
 Results: Based on the results of two measurements of the dental 
indexes, three  groups of  patients were  identified: 1)  those with 
good oral hygiene, 2) those with poor hygiene and positive dy- 
namics (improving dental health index), and 3) those with poor 
hygiene and negative dynamics (deterioration indexes). A relation- 
ship was found between dentist recommendations and patient per- 
sonal characteristics. 
 Summary: Most patients tried to follow the doctor's recommenda- 
tions for oral care, as evidenced by the decline in dental health 
indices in the second survey. Differences in patient personal char- 
acteristics, whether patients did or did not follow recommendations, 
and gender differences were found between groups with improve- 
ment and deterioration indexes. 
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Abstract 
Nowadays, the science of dental materials is intently focused on 
the creation of "ideal" filling material. The research carried out at 
the Dentistry Department of Voronezh State Medical University 
was motivated by the need to improve the properties of filling 
materials under the influence of an electromagnetic field to en- 
hance their physical and mechanical properties and to prevent den- 
tal complications. 
It is well known that filling materials used for dental caries prevention and 
treatment consist of various components, including synthetic polymers, 
which play an important role in forming the main structure of these 
materials as well as in their physical and chemical properties. 
Scanning electron microscopy (SEM) was used to study the properties of 
polymeric restorative materials before and after their exposure to the 
electromagnetic field in vivo, including a study of microstructural char- 
acteristics of filling materials. 
The SEM results confirmed the significant changes in the microstructure 
of polymeric restorative materials under the influence of an electromag- 
netic field, i.e. an improvement in their mechanical properties. 
Analysis of the data indicates the presence of microstructural changes in 
the physical and mechanical properties of filling materials after the elec- 
tromagnetic field exposure, namely increased strength under compres- 
sion, diametrical fracture and bending. 
These findings may contribute to increasing the service life of filling 
materials and preventing the occurrence of secondary caries, thus 
positively affecting the quality of treatment on the whole. 
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Abstract 
A number of authors consider rational oral hygiene an integral component 
of etiopathogenetic prevention of dental caries and periodontal disease. 
For in vitro studies and the evaluation of physical and chemical proper- 
ties, the structure and substructure of 30 toothpaste samples were exam- 
ined using a Libra 120 transmission electron microscope (ZEISS) with 
different techniques: fast electron diffraction, and bright-field and dark- 
field imaging. In vivo studies included clinical assessment of the state of 
hard dental tissues after the application of ROCS Sensitive Instant Relief 
toothpaste during the month before and after electromagnetic field 
exposure. 
The in vitro results revealed certain changes in the microstructure of the 
ROCS Sensitive Instant Relief toothpaste after electromagnetic field ex- 
posure consisting of compound particle enlargement and corresponding 
changes in density. 
According to the in vivo results, a reliable positive effect after the application of 
therapeutic toothpaste was achieved in 98% of cases. However, when it was 
exposed to the electromagnetic field, a greater anti-caries effect was observed, 
which was confirmed by numerous diagnostic techniques. 
Thus, as a result of the application of ROCS Sensitive Instant Relief 
toothpaste in the study group, the mean value of the dental hygiene index 
was reduced from 0.80 ± 0.06 to 0.50 ± 0.02 towards an improvement in 
oral hygiene status. The cariogenicity of dental plaque disappeared in 
most patients of the study group, which was confirmed by the statistical 
data, from 40.4 ± 2.53% before to 13.73 ± 1.82% after. There was no 
significant reduction in the control group indices. 
The studies thus revealed certain changes in the microstructure of ROCS 
Sensitive Instant Relief toothpaste caused by the electromagnetic field 
and in the ion-exchange processes in hard dental tissues during their 
use, which leads to a significant increase in their therapeutic and prophy- 
lactic efficacy. 
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Abstract The development of practical skills using simulation training 
eliminates the risk to patient’s health and life, provides a personalized 
approach to learning and the possibility of developing practical skills 
and bringing them to automatism, and ensures the objective control of 
the quality of their execution. 
Objective: to determine the effectiveness of a simulation method of 
teaching manual skills when handling removable dentures in a clinical 
setting. 
Methods: The first phase of the study involved 82 third-year students, 
divided into a control group where the training was conducted with the 
use of standard phantoms, and a study group that used a fifth-generation 
CDS 100 dental simulator. The second phase included 48 young special- 
ists who had participated in the first phase, and were divided into groups 
similar to those of the first phase. The quality of the preparation for the 
both stages was objectively assessed with a Zirkozahn S600 ARTI 
scanner. 
Results: In the control group, the main reason for the need for additional 
correction of the abutment teeth at both stages was inadequacy of the 
dental ledge, with an ANOVA factor indicator of 1.1 for the first phase 
and of 1.15 for the second, which indicates statistical identity of predic- 
tors in this group. The study group found no statistically significant dif- 
ference between the quality of the dental ledges executed at the first and 
second stages of the study, with an ANOVA factor indicator of 0.9, which 
indicates the statistical significance of such a predictor for preliminary 
acquisition of automatic movements acquired while working with the 
simulator. 
Conclusion: The use of the CDS 100 interactive dental simulator pro- 
vides a higher level of practical skills development and, most significant- 
ly, their "survival" compared with the classical form of education, which 
is confirmed by subsequent clinical practice. 
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Abstract 
The scientific data proving that enamel is a mineral and protein tissue 
with a system of microcirculation in the form of enamel tubules served as 
the basis for this study. The orifices of the enamel tubules open onto the 
enamel surface. The dental pulp fluid rushes out through enamel and 
dentinal canals because of the pressure gradient in the pulp. The chewing 
function is the only physiological mechanism to provide the pressure 
gradient. 
The aim of the study was to evaluate the functional state of superficially 
localized masseter and temporal muscles in adolescents aged 13–16 years with 
high and medium caries resistance, by means of electromyography. 
Electromyography was conducted to evaluate the masseter and temporal 
muscles in 62 adolescents aged 13–16. The assessment was carried out 
using the Synapsis apparatus. The degree of tooth caries development 
was determined by intraoral roentgen diagnostics using the de Götzen 
S.r.l. electrometric diagnostics dental apparatus and light-induced 
diagnostics. 
The electrobiological activity of the masseter muscles was found to be 
significantly lower in patients with medium caries resistance than in ad- 
olescents with high caries resistance. There was an imbalance between the 
electrobiological activity indices in the masseter and temporal muscles; 
an increase in masseter fatigue in response to a static load in adolescents 
with medium caries resistance was observed. That situation may lead to a 
reduced pressure gradient of the dental pulp fluid in the pulp cavity, its 
failure to enter enamel tubules, and consequently to lower enamel resis- 
tance, with the risk of a cariogenic situation in adolescents. 
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Abstract 
Objective. According  to  a number of authors, low-intensity  laser 
radiation contributes to a significant increase in the resistance of 
enamel to caries. The development of new methods of prevention 
with the use of physiotherapy, and the resulting decrease in the 
volume of medical measures and material costs, is highly relevant. 
The main purpose of this study is to assess the effectiveness of 
preventive measures to achieve an anticaries effect using MRL 
physiotherapy with the Svetozar device. 
Materials and methods. The Svetozar laser and photomedicine de- 
vice (wavelength, 628 nm; radiation width, 10 nm; pulse frequen- 
cy modulation, 76 Hz; wide interval pulses;  radiation  power,  6 
mW) was  used. Caries preventive measures were carried out  in 
30 patients aged 18 years. The teeth were dried and covered with 
fluoride varnish, and were then subjected to irradiation with the 
Svetozar for 2 min per tooth. The preventive measures were per- 
formed within 5 days, and the course was repeated in 6 months. 
Efficiency monitoring was carried out before and after treatment 
using acidic enamel biopsy according to V.K. Leontiev  and  the 
tooth plaque cariogenicity (TPC) evaluation. 
Results. Preventive therapy resulted in a 43% reduction in the rate 
of acid solubility of  enamel and a  54.8% decrease  if combined 
with fluoride varnish. The use of MRL resulted in 82.5% com- 
plete elimination of TPC. 
Conclusion. MRL plays an important role in caries prevention in 
adults, as it has a pronounced anti-caries effect on tooth enamel. 
If it is combined with fluoride varnish, it is possible to achieve a 
71.5% reduction in the growth of dental caries. 
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Abstract 
Bacterial pollution of air is associated with the existence of proinflamma- 
tory infections in surgical patients and the use of dental equipment dis- 
persing bacterial aerosols of the oral cavity during orthopedic and thera- 
peutic treatment. 
Objective: Scientific justification of the principles of cross infection pre- 
vention in dental care facilities. 
Materials and methods: We studied the material obtained in bac- 
teriological studies of 2160 air samples taken in dental rooms of 
different profiles, in winter and in summer, in the city and in the 
countryside. 
Results: The beginning of a working day is characterized by different 
levels of bacterial pollution of air in dental rooms of different profiles 
(surgical – 779 CFU/m3, therapeutic – 1702 CFU/m3, orthopedic – 1942 
CFU/m3). In the middle of a working day, bacterial pollution increases 
(surgical – 2075 CFU/m3, therapeutic and orthopedic – 2525 CFU/m3). 
At the end of a working day, the bacterial pollution rate is the highest 
(surgical – 2623 CFU/m3, therapeutic – 3701 CFU/m3, orthopedic – 3709 
CFU/m3). 
Bacterial pollution in dental rooms differs between summer and winter. 
At the beginning of a working day, the summer indices are higher than 
those of winter (winter – 1702 CFU/m3, summer – 2188 CFU/m3). In the 
middle of a working day, the summer indices are also higher (winter – 
2525 CFU/m3, summer – 2963 CFU/m3). At the end of a working day, 
however, the winter indices are higher (winter – 3701 CFU/m3, summer – 
3098 CFU/m3). 
Bacterial pollution in dental rooms differs between the city and the coun- 
tryside: at the beginning of a working day (city – 1702 CFU/m3, coun- 
tryside – 2370 CFU/m3); in the middle of a working day (city – 2525 
CFU/m3, countryside – 3366 CFU/m3); at the end of a working day (city 
– 3701 CFU/m3, countryside – 3827 CFU/m3). 
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Abstract 
This article covers the necessity of periodontal disease prevention 
at the individual level and development of new forms of peri- 
odontal care. 
Objective. To develop organizational and methodological principles for 
performing individual medical and preventive activities for periodontal 
disease as part of regular health examinations. 
Materials and methods. A total of 150 patients in group 1 (common 
preventive measures) and 150 patients in group 2 (individual approach) 
aged 19–45 were examined. Various methods were used to specify the 
extent and content of interventions, which included medical history, scan- 
ning electron microscopy (SEM), and electron microprobe analysis 
(EMPA). 
Results. Periodontal disease prevention was performed in accordance 
with the three-stage principle: selection, recording, monitoring. 
Significant changes in oral hygiene status were registered in pa- 
tients of group 2 in the 3 years after initiation of the program. 
Among patients, 16.7% needed periodontal disease treatment, 
which was 4.2-fold lower than before the  preventive  programs 
were implemented. The reduction in clinical indices was greater 
than 85%. These findings indicated increased resistance of tooth 
enamel to caries. No significant  changes  were  observed  in  the 
oral hygiene status in  patients  of  group  1  for  the  duration  of 
the observation period. 
Conclusion. Based on the results,  we  can  conclude  that  medical 
and preventive activities based on dynamic observation contribute 
to a significant decrease in the incidence and intensity of peri- 
odontal pathology in certain groups of patients, as well as  im- 
proved teeth and oral mucosa health. 
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Abstract 
The functional pattern of the tongue neuromuscular apparatus and its 
morphological characteristics plays an important role in the develop- 
ment of the majority of malocclusion disorders. Based on an analysis 
of the scientific literature, there is no unified position regarding the 
research methodology and the treatment protocol for ankyloglossia 
combined with malocclusion. In the present study, the strength pa- 
rameters of tongue muscles were evaluated in patients with 
ankyloglossia before and during the course of treatment. The research 
program involved a group of patients with ankyloglossia which in- 
cluded 39 children age 7 to 9 years. The control group included 20 
children of similar age. In the patients of the base group, 
motivational-oriented activities such as frenuloplasty, orthodontic 
therapy, and instrumental myotherapy were conducted. The strength 
parameters of the tongue were evaluated using the IOPI Medical 
system. In the base group, a significant reduction in the strength of 
the tongue elevation muscles was observed. 
With closed mouth, the force parameters were reduced by 27.3%, 
and with open mouth by 59.16%, in comparison with the results of 
the control group (р<0.05). Functional therapy resulted in an in- 
crease in the strength activity of the tongue as well as its endurance 
indicators. Thus, the implementation of frenulotomy combined with 
subsequent orthodontic therapy and myotherapy leads to an increase 
in the strength parameters of the tongue muscles. The use of a 
technology to increase children’s motivation for treatment is a de- 
terminant of the enhancement of tongue muscle endurance and the 
active remodeling of the tongue’s functional pattern. 
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Abstract 
A sequence of therapeutic and diagnostic stages of orthopedic 
treatment and prophylaxis in patients with chronic oral mucosal 
diseases based on the complex application of the soft base mate- 
rial Mollosil plus and Hepon immunomodulating preparation has 
been developed and described. Forty patients were divided into 
groups. The patients underwent a complete dental examination, X- 
ray studies, bacteriological examination, bacterioscopy and immu- 
nological examination of saliva. The assessment of the condition 
of the mucosa was carried out on days 3 and 10. 
During the objective assessment of prosthetic bed mucosa, it was 
revealed that the greatest number of patients with diffuse hyper- 
emia had occurred on the third day. When studying the nature of 
changes in the mucous membrane of the prosthetic bed, along the 
integrity disturbance of the epithelial cover, on the third day after 
the prosthetics, we registered a significantly lower amount of 
traumatic erosion in 50% of patients who received an 
immunomodulating therapy. In patients of this group, the content 
of s-IgA in saliva increased significantly throughout the period of 
observation, and the IgA and IgG values after a certain increase 
on the tenth day subsequently returned to the baseline  level 
(0.125 ± 0.005 М ± m). The reduction in local humoral immunity 
intensity in patients taking Hepon was accompanied by the acti- 
vation of cellular immunity, which was evidenced by increased 
phagocytic number (5.0 ± 0.3) and phagocytic  index  values 
(42.0 ± 1.2). Throughout the period of adaptation to the prosthe- 
ses, 80% of patients expressed positive dynamics in the reduction 
of the area of inflammation by 20% (2.5-fold). 
The effectiveness of treatment in patients with chronic oral mucosal dis- 
eases was proved by the removable orthopedic prosthesis design on the 
basis of clinical and laboratory studies of the complex application of 
elastic base material and immunocorrection. 
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Abstract 
The search for available and effective products for inflammatory peri- 
odontal disease prevention is an important objective in preventive 
dentistry. 
From a great variety of oral rinses, we chose the most commonly 
used 0.05% chlorhexidine solution and the new preparation 
Dentaseptin, due to the significance of their use for periodontal dis- 
ease prevention. 
We examined 50 patients aged 40–50 years; an unsatisfactory oral 
hygiene index (more than 1.7) was observed in 70%, which indi- 
cates the presence of inflammatory periodontal disease. The patients 
were divided into two groups who brushed their teeth twice a day 
with individually selected toothbrush and toothpaste. Twenty pa- 
tients from the control group used chlorhexidine as an oral rinse, 
and 30 patients from the study group used Dentaseptin for oral 
cavity rinsing. The results in the study group showed 30% improve- 
ment in oral health compared to the control patients (p<0.01), which 
demonstrates its positive effects and opens the possibility for 
recommending it for wide use in dentistry. 
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Abstract 
Nowadays there is a high demand for local anesthesia during a dental 
patient visit. The follow-up rate of patients with cardiovascular disease is 
one-third of the number applying for dental care (J. A. Baart, H. S. Brand, 
2010, 2015). Prevention of the risk of complications in these patients with 
the use of high-tech anesthetics is a priority for every dental doctor. 
At the dental departments of Voronezh State Medical University, 100 
patients aged 45–70 years were examined. Among these patients, 53% 
applied for treatment of complicated forms of caries and 47% applied for 
teeth removal due to complications of chronic periodontitis. The analysis 
of medical histories of patients and their clinical records, as well as advi- 
sory expert opinions, revealed the presence of cardiovascular disease. In 
86% of cases, the examined had different cardiovascular diseases or their 
combinations; 79% had hemodynamic disorders due to atherosclerosis of 
the heart and brain vessels. As pain causes a significant increase in the 
amount of adrenaline released during dental procedures, patients with 
ischemic heart disease and essential hypertension need adequate 
anesthesia. 
Therefore, this category of patients was recommended for use of adrenaline 
only at a dilution of 1:100.000 and 1:200.000 with restriction of its quantity. 
Thus, the elimination of cardiovascular complications is explained by an 
individualized approach to the choice of anesthetic during anesthesia, which 
will allow for effective dental treatment. Keeping the oral cavity in good 
condition plays a key role in general well-being and quality of life. 
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Abstract 
In Russia, the principle criterion for children’s dental health is tradition- 
ally considered the DMFT (total number of decayed, missing and filled 
teeth) index. This criterion does not allow identification of individual risk 
factors for dental health and, even more importantly, determining the 
directions of individualized prevention of dental diseases. 
The present research evaluates the informativeness of a number of the 
European Community Health Indicators of dental health among 116 
13-year-old schoolchildren from Voronezh, according to the following 
criteria: the percentage of healthy children, the average value of the 
DMFT index and its components, the prevalence of gingival bleeding, 
and the oral hygiene index, as well as a number of subjective criteria 
related to behavioral habits. 
The objective indicators (dental status data) revealed the need for preven- 
tive and/or non-emergency treatment in 93% and the need for emergency 
dental treatment in 11%, among many others. The subjective indicators 
(questionnaire survey data) revealed the ineffectiveness of preventive 
measures in more than 53% of respondents. 
European indicators of dental health have made it possible to assess the 
main negative objective and subjective trends in society and to develop 
mass and personalized preventive and hygienic measures [1, 2]. 
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Abstract 
The primary detection and diagnosis of periodontal disease using con- 
ventional diagnostic methods is not informative, does not reveal features 
of the pathological process, and does not predict the outcome of therapy 
based on etiology and pathogenesis. The gingival crevicular fluid is high- 
ly informative in a study focused on searching for methods for the early 
diagnosis and detection of periodontal disease. In our study, data of var- 
ious parameters of the gingival crevicular fluid and its correlation with the 
development of pathological processes in the periodontium are 
summarised. Previously, we studied 120 subjects of both genders aged 
18–25 years and analyzed data of cytological and bacterioscopic investi- 
gations, public health research methods and physical examination, and 
investigation of multiple enzymes in the gingival crevicular fluid. The 
results revealed that at the early stages of inflammation in periodontal 
tissue, the cocci population increases and forms clusters, mature 
pseudomycelium of yeasts increases up to 8–10 colonies in the field of 
view, and immature epithelial cells with nuclear-to-cytoplasmic ratio of 
1:2 appear. Recent studies have shown that F. alocis has high potential for 
the early diagnosis and detection of periodontal disease. This is due to the 
fact that F. alocis and P. gingivalis are able to generate mixed colonies and 
coexist. For example, enzymes of F. alocis can induce P. gingivalis to 
reproduce and spread, enhancing its virulence. Our preliminary data col- 
lected in a study consisting of 45 subjects have shown interesting findings 
in cytology and bacterioscopy. An increase in the number of F. alocis and 
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P. gingivalis led to an increase in streptococci and fungi, and vice versa. 
All of the above constitutes evidence that cytology and bacterioscopy are 
highly informative methods for early detection of periodontal disease. 
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Abstract 
The main reason for tooth loss is inflammatory periodontal dis- 
ease. That is why early diagnostics, timely prevention and com- 
plex treatment are necessary to relieve the inflammatory process 
in order to recover or to achieve  sustained  remission  within  a 
short time. Treatment should start with the removal of dental 
calculus, plaque and biofilms from the teeth surfaces. The 
Vector System (Durr-Dental, Germany) and ultrasonic scalers are 
used for this. According to a number of authors, however, its 
bactericidal effect is not enough to achieve sustained long-term 
remission. Ozone therapy is considered an effective method of 
treatment of  inflammatory diseases.  However,  ozone has  only a 
superficial antimicrobial action. 
Thus the purpose of our research was to assess the efficiency of complex 
treatment of inflammatory periodontal disease using the Vector System 
with ozonized water. 
We examined 151 patients,  who  were  divided  into  two  groups: 
the main group (91 people)  and  the  control  group  (60  people). 
The control patients received traditional treatment, and the main 
group received vector  therapy with  ozonized water.  Relief from 
inflammation was achieved in a shorter time (on the second day) 
in the main group, with treatment time reduced to half; 96% of 
these patients experienced  remission  for 1 year, whereas 4% of 
patients had only primary signs of inflammation. The patients inf 
the control group experienced mild inflammation on the seventh 
day, and remission lasted for 6 months in 43% and for 3 months 
in 57% of patients. 
The advantage of this method of periodontal disease treatment compared 
to traditional treatment has been proven by clinical, bacterioscopic and 
radiological indicators. 
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Abstract 
For 25 years we have been publishing research papers confirming the anti- 
caries effect of fluoride in persons who have not reached a particular age (15.5 
years) [1]. Unfortunately, at present, toothpastes with high fluo- 
ride content are being promoted for both adults and children. 
More than 150 patients between the ages of 20 and 40 were placed under our 
observation, all of whom used the fluoride-free ROCS brand toothpaste to 
maintain their oral hygiene. The control group comprised over 100 patients 
who used toothpastes containing fluoride. The results were measured using 
electron microscopy, and microchemical and clinical methods. The reduction 
in caries was 84.5% in the study group and only 62.3% in the control group 
(p<0.05). Electron and atomic force microscopy studies in the first group 
showed that magnesium contained in the toothpaste was actively integrated 
into the hydroxyapatite crystal cells in the enamel. The fluoride that was 
present in the control group toothpaste was not detected on the chemical 
spectrum of the enamel, but nevertheless had a strong bactericidal effect. 
The studies showed that the presence of magnesium inside the enamel struc- 
ture increased from 1.5 to 2.7 μmol/L (p<0.05) in adult patients, with only 
trace amounts of fluoride found (0.1), confirming the fact that toothpastes 
containing magnesium play an active role in strengthening enamel crystal cells. 
As such, electron and atomic force microscopy studies with 
microchemical spectrum determination have confirmed the caries- 
resistant effect (clinical) that occurs when using fluoride-free toothpaste. 
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